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ABSTRACT 
 
MEMORY RETRIEVAL IS MAINTAINED BY INTRINSIC AND  
SYNAPTIC PLASTICITY IN PRELIMBIC CORTEX 
 
by 
 
James M. Otis 
 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Devin Mueller 
 
 
Abnormally strong memories underlie common disorders including addiction and post-
traumatic stress disorder (PTSD).  Memory disruption would therefore be beneficial for 
treatment of these disorders.  Evidence reveals that cocaine conditioned place preference 
(CPP) memories are susceptible to long-lasting disruption during memory retrieval.  For 
example, inhibition of β-adrenergic receptor (β-AR) activity within the prelimbic medial 
prefrontal cortex (PL-mPFC) prevents cocaine CPP memory retrieval, and this retrieval 
impairment is both long-lasting and prevents subsequent reinstatement of the CPP.  
Despite this, whether PL-mPFC β-AR activity is a fundamental mechanism required to 
maintain retrieval of other memories is unclear.  Furthermore, how PL-mPFC β-AR 
activity maintains memory retrieval is unknown.  Thus, here I use a combination of 
behavioral and electrophysiological techniques to 1) evaluate how PL-mPFC β-AR 
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activity regulates retrieval of memories related to a natural reward and to an aversive 
stimulus and 2) to determine the mechanism of memory retrieval deficits.
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Introduction 
 Potentially rewarding or threatening stimuli are particularly relevant to an 
organism.  Presentation of these stimuli augments arousal and attention, and ensuing 
improvement of sensory perception, learning, and memory allows fast and accurate 
responses to a potential reward or threat (Sara and Bouret, 2012).  Although this increases 
the likelihood of survival within an environment, stimulus-induced enhancement of 
learning and memory can also become problematic. 
 Pathological forms of memory drive inappropriate behaviors that are destructive 
to normal health and behavior.  Disruption of these memories would therefore be 
beneficial for treatment of memory-related psychiatric diseases.  Here, I use drug 
addiction and post-traumatic stress disorder (PTSD) as model diseases to describe how 
pathological forms of memory can lead to disordered behaviors.  Moreover, research 
regarding memory disruption, particularly by β-adrenergic receptor (β-AR) blockade 
during memory retrieval, is described.  The mechanisms by which β-AR blockade 
disrupts memory retrieval are not known.  Thus, a series of experiments were performed 
using a combination of behavioral and electrophysiological techniques to 1) determine 
the mechanism of memory retrieval impairments and 2) evaluate whether β-AR activity 
during memory retrieval is a fundamental mechanism required for the maintenance of 
memories. 
 
Natural and pathological appetitive learning 
  Survival and reproduction depend on obtaining rewards such as food, shelter, and 
sex.  To obtain these rewards efficiently an organism must learn based on previous 
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experiences.  For example, environmental stimuli become associated with a reward as 
positively reinforced behaviors are completed (Pavlov, 1927).  Following this learning, 
presentation of reward-related cues can motivate behaviors which have previously been 
reinforced by that reward (Hyman, 2005).  Unfortunately, stimulus-reward learning can 
become too strong, leading to pathological forms of appetitive memory. 
 Drug abuse induces the formation of strong associations between environmental 
stimuli and drug effects.  Presentation of drug-associated cues can subsequently provoke 
abnormal autonomic responses and subjective reports of craving among addicts 
(Childress et al., 1986a, b; Ehrman et al., 1992), and these cravings drive compulsive 
drug seeking (Herman, 1974; O'Brien et al., 1991).  Unfortunately, compulsive drug 
seeking can persist despite negative consequences (e.g., withdrawal, illness, anxiety, and 
intoxication) and this behavior can supplant healthy, positively reinforcing behaviors.  
However, disruption of drug-associated memories would prevent cue-induced drug 
seeking, limiting relapse susceptibility. 
 
Natural and pathological fear learning 
 Survival also depends on learning to avoid and escape danger.  Stimuli that are 
coupled with a perceived threat, such as the howl of a predator, become associated with 
the danger.  Following this learning, presentation of the threat-associated stimuli can 
drive the behaviors that promote avoidance of the threatening stimulus.  However, fear 
learning can also become problematic. 
 Traumatic experiences, such as combat or a violent assault, can lead to PTSD.  
This disorder develops gradually following a trauma, and initial symptoms include 
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cognitively re-experiencing the event even with attempts to avoid such thoughts (Grillon 
et al., 1996).  This leads to a pathological form of memory, in which cues associated with 
the event are particularly capable of reminding the patient of the trauma.  Thus, 
presentation of trauma-related cues (e.g., a noise) can induce an exaggerated fear 
response, which may include startle, perspiration, shortness of breath, and panic.  
However, disruption of traumatic memories would be beneficial for treatment of PTSD 
(Pitman et al., 2002; Brunet et al., 2008). 
 
Memory acquisition, consolidation, retrieval, and reconsolidation 
 Appetitive and aversive learning require overlapping neural mechanisms (Peters 
et al., 2009).  Research reveals that formation and expression of these memories occurs in 
several stages, including acquisition, consolidation, retrieval, and reconsolidation (Abel 
and Lattal, 2001; Nader and Hardt, 2009).  First, memory acquisition is the earliest stage 
of learning, during which an association exists as a short-term memory.  Second, memory 
consolidation is the process by which a short-term memory becomes long-term.  Third, 
memory retrieval is the reactivation of a consolidated memory, allowing memory recall 
and/or behavioral expression of the memory.  Therefore, consolidated memories are not 
functional if memory retrieval is disrupted.  Last, memory reconsolidation is the process 
by which a retrieved memory becomes labile and is again consolidated into long-term 
storage.  Reconsolidation likely reflects “memory updating”, and recent research reveals 
that many types of memories are susceptible to disruption during this process (Nader and 
Hardt, 2009).  Thus, memory retrieval and reconsolidation are of particular importance to 
disorders associated with pathological forms of memory, as disruption of these processes 
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could prevent cue-induced behaviors.  To understand the mechanisms required for 
retrieval and reconsolidation, neuroscientists use rodent memory models.  Next, I focus 
on three rodent models that are used to study memory. 
 
Conditioned place preference 
 The conditioned place preference (CPP) paradigm is commonly used to 
investigate the neural mechanisms of drug-associated memories.  In this paradigm, rats 
are trained to associate one chamber, but not another, with a drug of abuse.  Following 
training, all rats are given full access to both chambers while in a drug-free state.  During 
these CPP trials more time is spent within the drug-paired chamber than within the saline-
paired chamber.  Thus, a CPP for the previously drug-paired chamber is expressed.  
When a CPP is expressed investigators can be certain that animals acquired, consolidated, 
and retrieved the drug-associated memory.  Moreover, the mechanisms underlying these 
processes can be investigated through pharmacological manipulation at different time 
points throughout CPP experiments.  For example, the mechanisms underlying drug-
associated memory retrieval can be examined via pharmacological manipulation before a 
drug-free CPP trial.  The effects of such manipulation can be determined by assessing 
CPP expression during the CPP trial.  In contrast, memory reconsolidation can be studied 
by manipulating the rodents immediately after a retrieval trial.  The effects of that 
manipulation can then be assessed during another CPP trial the following day.  Thus, the 
CPP procedure allows for the investigation of drug-associated memory retrieval and 
reconsolidation.  
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Self-administration  
 The self-administration paradigm is seldom used to study drug-associated 
memories, possibly due to confusion regarding the proper methods required to investigate 
memory within this model.  In the self-administration paradigm, rats learn to press a lever 
for an intravenous infusion of a drug.  Moreover, drug infusions are paired with cues that 
become associated with drug availability.  Drug self-administration training takes a series 
of days to weeks, such that the behavior becomes well-rehearsed and probably habitual.  
Consistent with this idea, even limited cocaine self-administration can cause insensitivity 
to devaluation of cocaine, indicating that self-administration becomes a behavior that is 
not goal-oriented (Zapata et al., 2010).  Moreover, this habitual cocaine seeking is 
blocked by inactivation of the dorsal striatum, a structure that is critical for habit learning 
(Zapata et al., 2010).  In contrast, goal-oriented cocaine seeking is not blocked by dorsal 
striatum inactivation (Zapata et al., 2010).  Thus, drug self-administration becomes a 
habitual behavior, and likely depends on neural circuits responsible for habit learning, but 
not memory retrieval.   
 Consistent with the idea that self-administration becomes a habitual behavior; 
data suggest that self-administration becomes independent of brain structures that are 
critical for memory retrieval, particularly the prelimbic medial prefrontal cortex (PL-
mPFC).  PL-mPFC is critical for memory retrieval (Corcoran and Quirk, 2007; Peters et 
al., 2009; Otis et al., 2013), and PL-mPFC activation is necessary for acquisition of an 
operant response before an action becomes habitual (Killcross and Coutureau, 2003; 
Ostlund and Balleine, 2005).  Thus, drug self-administration may become independent of 
PL-mPFC during training.  Indeed, inactivation of the PL-mPFC prevents the acquisition 
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of self-administration, but has no effect directly after self-administration training (Di 
Ciano et al., 2007).  Thus, drug self-administration becomes 1) habitual and dependent on 
neural circuits responsible for habit learning and 2) independent of goals and independent 
of neural circuits responsible for memory retrieval.  Importantly, extinction learning is 
likely to reverse this distinction, such that drug self-administration becomes dependent on 
memory retrieval.  
 Following drug self-administration training, rats undergo extinction during which 
lever presses do not lead to drug infusions.  To study memory retrieval, extinction must 
occur in the absence of drug-associated cues or within an alternative context.  This allows 
for extinction of the habitual behavior (lever pressing), but not extinction of the drug-cue 
or drug-context memories.  Following successful extinction training, rats no longer press 
the lever for the drug.  However, drug seeking can be reinstated upon re-presentation of 
the drug-associated cue or context.  As drug seeking at this time is no longer habitual, cue 
or context-induced reinstatement is likely to require memory retrieval.  In support of this, 
many studies reveal that cue-induced and context-induced reinstatement of drug self-
administration is PL-mPFC dependent (Capriles et al., 2003; McLaughlin and See, 2003; 
Fuchs et al., 2005; Ball and Slane, 2012).  Thus, cue-induced reinstatement and context-
induced reinstatement allow for investigation memory retrieval within the self-
administration paradigm.   
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Fear conditioning  
 Fear conditioning is a commonly used model of aversive learning and memory.  
In this paradigm, rats are trained to associate a conditional stimulus (CS), such as a 
context or an auditory tone, with an aversive unconditional stimulus (UCS), such as a 
foot shock.  Along with context fear conditioning, two distinct types of cued fear 
conditioning are commonly used.  First, delay fear conditioning involves the presentation 
of a CS that terminates with the UCS.   Second, trace fear conditioning involves the 
presentation of the CS and UCS, but these stimuli are separated in time by a silent ‘trace 
interval’.  Thus, trace fear learning is slightly more complex and requires more neural 
processing, such as PL-mPFC activation during the trace interval (Runyan et al., 2004; 
Gilmartin and McEchron, 2005; Gilmartin and Helmstetter, 2010; Gilmartin et al., 2013).  
Following context, delay, or trace fear conditioning rats are tested via presentation of the 
CS (context or discrete cue) in the absence of the UCS during fear memory retrieval tests.  
During this test, presentation of the CS induces a conditional response (CR), such as a 
rise in heart rate, blood pressure, and/or freezing of movement.  If rats express a CR 
following presentation of the CS, investigators can conclude that the animals acquired, 
consolidated, and retrieved the fear-associated memory.  Similar to place conditioning, 
the mechanisms underlying fear memory retrieval can be studied via manipulations 
before a CS test, whereas the mechanisms underlying reconsolidation can be studied via 
manipulations after a CS test.   
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Memory retrieval and noradrenergic signaling 
  Memory retrieval can be operationally defined as the neural process by which a 
consolidated memory is reactivated.  Retrieval allows for conscious recollection and 
behavioral expression of memory.  It is important to note that investigations of memory 
retrieval in rodents actually use behavioral expression to make inferences regarding 
memory retrieval.  Although impairments in memory retrieval would prevent behavioral 
expression of the memory, behavioral expression can also be disrupted by influencing 
nonspecific factors such as motor activity, motivation, and attention.  Thus, researchers 
should be careful with interpretations when investigating memory retrieval.  Moreover, 
when making conclusions regarding memory retrieval it is critical to run experiments that 
control for nonspecific effects of the manipulations on behavioral expression of memory.    
  The neural mechanisms underlying memory retrieval are not well understood.  
Early studies revealed that behavioral expression of memories can be enhanced by 
cocaine (Rodriguez et al., 1993), amphetamine (Sara and Deweer, 1982), and nicotine 
(Faiman et al., 1992).  These drugs are nonspecific, although each is capable of 
enhancing noradrenergic signaling.  More specific agonists of noradrenergic signaling 
have also been given during a retrieval test in the memory forgetfulness task.  In this 
paradigm, rats learn and over time forget a path which will guide them to the end of a 
maze.  Enhancement of noradrenergic signaling, via inhibition of α2-adrenergic 
autoreceptors which inhibit norepinephrine release, enhances behavioral performance in 
the maze after forgetting (Sara and Devauges, 1989).  Similarly, stimulation of the locus 
coeruleus (LC), a major nucleus of noradrenergic cell bodies (Dahlstroem and Fuxe, 
1964), also enhances memory expression in this task (Sara and Devauges, 1988).  Finally, 
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the enhancement of memory expression by LC stimulation is prevented by the β-
adrenergic receptor (β-AR) antagonist propranolol (Devauges and Sara, 1991).  Taken 
together, these studies indicate that memory retrieval may be enhanced by stimulation of 
noradrenergic signaling, and that this effect is dependent on β-AR activation. 
  Stimulation of noradrenergic signaling enhances memory expression, although it 
was unclear whether noradrenergic signaling is necessary for memory retrieval.  
Murchison and colleagues (2004) addressed this issue by using mice which lack 
dopamine β-hydroxylase (DBH), a necessary enzyme for norepinephrine and epinephrine 
synthesis from dopamine.  DBH knockout mice expressed fear during the learning phase 
of a contextual fear task but were unable to express this memory 1 to 4 days later.  
Similar results were also found in the Morris water maze, another spatial memory 
paradigm.  Interestingly, memory expression for DBH knockout mice was intact in a 
variety of discrete cue-induced memory tasks.  Furthermore, wild-type mice treated with 
β-AR antagonists expressed less fear during a contexual retrieval test, whereas mice 
treated with β-AR agonists expressed more fear during a contextual retrieval test 
(Murchison et al., 2004).  Interestingly, these effects were not present in a variety of 
discrete cued tasks, allowing the researchers to control for nonspecific effects of the 
manipulations on behavioral expression of the memory.  Thus, these data demonstrated 
that retrieval of contextual memories is dependent on β-AR signaling. 
  Although the evidence described indicates that β-AR signaling mediates retrieval 
of contextual, but not discrete cued memories, other evidence is at odds with this 
distinction.  For example, systemic injections of propranolol, a β-AR antagonist, reduces 
cue-induced fear expression in rats (Rodriguez-Romaguera et al., 2009).  Moreover, 
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propranolol reduces the firing rate of prelimbic medial prefrontal cortex (PL-mPFC) 
neurons in vivo (Rodriguez-Romaguera et al., 2009), a structure that is necessary for 
expression of fear memories (Corcoran and Quirk, 2007).  Thus, whether β-AR activation 
is required for both context and discrete cue-induced memory retrieval remains unclear. 
 
Persistent retrieval impairments in humans and rodents 
 Despite evidence supporting β-AR involvement in retrieval, only a few studies 
have examined whether this activity is required to successfully maintain future memory 
retrieval.  Recent data reveals that propranolol disrupts recall of visual memories and 
emotional words in humans (Kroes et al, 2010; Kroes et al, 2012 SfN Abstracts) and 
heroin-related words in human heroin addicts (Zhao et al., 2010).  Moreover, the effects 
of β-AR blockade on memory recall in humans are long lasting (Kroes et al., 2010), and 
may prevent memory reinstatement (Kroes et al, 2012 SfN Abstracts).  Although these 
findings are somewhat surprising given current models of memory, recent data support 
the conclusion that memory retrieval can be persistently impaired by β-AR blockade. 
 We recently investigated the effects of β-AR blockade on drug-associated 
memory retrieval in rodents.  Using a cocaine-induced CPP paradigm, we found that 
systemic injections (Otis and Mueller, 2011), PL-mPFC microinfusions (Otis et al., 
2013), or dorsal hippocampus (dHipp) microinfusions (Otis et al., 2014a) of β-AR 
antagonists prevents CPP memory expression.  Similar to human studies, the effects of β-
AR blockade on CPP expression persisted during subsequent days in the absence of 
further propranolol treatment.  Moreover, these memory impairments prevented 
subsequent cocaine-induced reinstatement of a CPP (Otis and Mueller, 2011; Otis et al., 
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2014a).  Below, I thoroughly describe these data and associated control studies which led 
to the conclusion that CPP memory retrieval can be persistently impaired by β-AR 
blockade during retrieval. 
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Otis and Mueller, 2011 
 We first investigated the necessity of β-AR activation for cocaine-associated CPP 
memory retrieval.  Rats were conditioned to associate one chamber with cocaine (10 
mg/kg or 20 mg/kg) and another with saline before daily CPP tests.  Moreover, rats were 
given systemic injections of saline or the β-AR antagonist propranolol before the first 
CPP test only.  Rats treated with saline expressed a CPP for the previously cocaine-
associated chamber during the first CPP test and during all subsequent tests overall, 
whereas rats treated with propranolol did not (see Figure 1A and Figure 1B).  We next 
replicated these findings, but rats were injected with saline or propranolol before the 
second CPP test.  All rats expressed a CPP during the first injection-free test.  Moreover, 
rats treated with saline expressed a CPP for the previously cocaine-associated chamber 
during the second CPP test and during subsequent injection-free trials overall.  In 
contrast, rats treated with propranolol did not express a CPP during the second test or 
during subsequent propranolol-free tests (see Figure 2).  We again replicated these 
findings but injected rats with saline or propranolol before the second, third, and fourth 
CPP tests.  All rats expressed a CPP during the first injection-free test.  Moreover, rats 
treated with saline expressed a CPP during all subsequent CPP tests overall, including an 
injection-free CPP test 2 weeks later.  However, propranolol-treated rats did not express a 
CPP during these tests or during the injection-free test 2 weeks later (see Figure 3).  Thus, 
systemic administration of propranolol before the first or second CPP test prevented the 
expression of a cocaine-induced CPP memory, and this effect persisted for a minimum of 
2 weeks. 
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 Multiple unreinforced CPP tests lead to extinction learning, resulting in no CPP 
expression during subsequent tests.  Following extinction, reinstatement of a CPP can be 
induced via administration of cocaine (Mueller and Stewart, 2000).  Thus, we determined 
whether the persistent CPP expression deficit prevented cocaine-induced reinstatement of 
the CPP.  Following conditioning, rats were treated with saline or propranolol before the 
second, third, and fourth CPP tests.  Behaviorally, both extinction learning and 
propranolol treatment abolish CPP expression.  Thus, rats treated with saline received an 
extra 8 CPP extinction tests of longer duration (30 minutes) to ensure extinction of the 
CPP.  During the final CPP test, neither saline- nor propranolol-treated rats expressed a 
CPP.  The following day, rats previously treated with saline expressed cocaine-induced 
reinstatement of the CPP, whereas rats previously treated with propranolol did not (see 
Figure 4).  Thus, previous treatment with propranolol provided long-lasting protection 
against cocaine-induced reinstatement of the CPP. 
 Propranolol has effects on both the central and peripheral nervous systems (Street 
et al., 1979), and therefore the effects of propranolol on CPP expression could be due to 
β-AR blockade in either system.  To investigate this, we administered sotalol, a 
peripheral β-AR antagonist that does not cross the blood-brain barrier (Dahlof, 1981), 
before the second, third, and fourth CPP tests.  Rats treated with saline and sotalol 
expressed a CPP during the first CPP test and during subsequent tests overall (see Figure 
5).  Thus, sotalol did not prevent CPP memory expression, indicating that the effects of 
propranolol are due to β-AR blockade in the central nervous system. 
 Propranolol has effects that are not specific to β-AR blockade when administered 
at high doses, including protein kinase C inhibition and serotonergic receptor blockade 
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(Alexander and Wood, 1987; Sozzani et al., 1992).  Thus, we examined the effect of a 
low dose of (-)-propranolol (1 mg/kg), the more active enantiomer which is more 
selective for β-ARs. Following conditioning, rats were given systemic injections of saline 
or (-)-propranolol before the first CPP test.  Rats treated with saline expressed a CPP for 
the previously cocaine-associated chamber during the first CPP test and during all 
subsequent tests overall, whereas rats treated with (-)-propranolol did not (see Figure 
6A).  Thus, a low dose of (-)-propranolol induced a persistent disruption of CPP 
expression, supporting the conclusion that the effects of propranolol on CPP expression 
are specific to β-AR blockade. 
 Propranolol and other β-AR antagonists are capable of preventing CPP memory 
reconsolidation (Bernardi et al., 2006; Fricks-Gleason and Marshall, 2008; Bernardi et 
al., 2009).  Thus, the persistent effects of propranolol on CPP expression could be 
attributable to reconsolidation blockade.  To investigate this, following conditioning rats 
were given systemic injections of saline or propranolol immediately before, instead of 20 
minutes before the first CPP test.  In this case, propranolol is unlikely to have effects until 
after the CPP trial, during memory reconsolidation and after a CPP has already been 
expressed.  Rats treated with propranolol expressed a CPP for the previously cocaine-
associated chamber during the first CPP test and during subsequent CPP trials overall 
(see Figure 6B).  Thus, propranolol administration immediately before a CPP test did not 
prevent subsequent CPP expression.  Taken together, these data reveal that propranolol 
persistently impairs CPP expression without having effects on memory reconsolidation. 
 We also examined whether propranolol induced an affective state capable of 
altering CPP expression, or if propranolol altered locomotor activity.   Rats were 
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conditioned to associate one chamber with propranolol and another with saline.  
Following conditioning, rats were given a CPP test during which no CPP or aversion was 
expressed for the previously propranolol-paired chamber (see Figure 6C).  Thus, 
propranolol itself does not induce an affective state capable of influencing CPP 
expression.  Finally, we determined the effects of propranolol on locomotor activity by 
measuring the number of photobeam breaks during a CPP trial.  Rats treated with saline 
and propranolol had equivalent photobeam breaks during the CPP trial, indicating that 
propranolol did not influence locomotor activity (see Figure 6D).  Taken together, the 
effects of propranolol are not attributable to reconsolidation blockade or other 
nonspecific effects on behavioral expression of the memory.  Thus, β-AR blockade 
persistently impairs CPP memory retrieval, and this provides protection against 
subsequent cocaine-induced reinstatement. 
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Figures:  Otis and Mueller, 2011 
Figure 1 
 
Figure 1.  β-AR blockade persistently impairs cocaine CPP memory expression.  
Following conditioning with (A) 10 mg/kg or (B) 20 mg/kg of cocaine, systemic 
injections of propranolol, but not saline, before the first CPP trial prevented rats from 
expressing a cocaine CPP.  Rats previously treated with propranolol, but not saline, 
continued to express no cocaine CPP during subsequent propranolol-free trials (Otis and 
Mueller, 2011).  ***p < 0.001, **p < 0.01, and *p < 0.05.   
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Figure 2 
 
Figure 2.  β-AR blockade persistently impairs cocaine CPP memory expression when 
administered before the second CPP trial.  Following conditioning, systemic injections of 
propranolol, but not saline, before the second CPP trial persistently impair CPP 
expression (Otis and Mueller, 2011).  ***p < 0.001 and *p < 0.05. 
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Figure 3 
 
Figure 3.  Effects of β-AR blockade on CPP expression are long-lasting.  (A) Systemic 
injections of propranolol, but not saline, before the second, third, and fourth CPP trials 
persistently impair CPP expression.  (B) Rats previously treated with propranolol, but not 
saline, continued to express no CPP following a 14-day break from testing (Otis and 
Mueller, 2011).  ***p < 0.001, **p < 0.01, and *p < 0.05.  
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Figure 4 
 
Figure 4.  Effects of β-AR blockade on CPP expression prevent subsequent cocaine-
induced reinstatement.  Rats treated with saline or propranolol expressed no CPP during 
the final CPP extinction trial.  Rats previously treated with saline, but not propranolol, 
expressed cocaine-induced reinstatement of the CPP (Otis and Mueller, 2011).  Sal, 
saline; Prop, propranolol; **p < 0.01. 
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Figure 5 
 
Figure 5.  Peripheral β-AR blockade has no effect on CPP expression.  Rats treated with 
sotalol did not prevent CPP expression across trials (Otis and Mueller, 2011).  ***p < 
0.001, **p < 0.01, and *p < 0.05. 
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Figure 6 
 
Figure 6.  Effects of systemic propranolol injections on CPP expression are not due to 
nonspecific effects.  (A) Systemic injections of (-)-propranolol, but not saline, induced a 
persistent deficit in CPP expression.  (B) Systemic injections of propranolol immediately 
before a CPP trial did not completely prevent subsequent CPP expression.  (C) Rats spent 
an equivalent amount of time within previously propranolol-paired and saline-paired 
chambers.  (D) Systemic injections of propranolol did not affect locomotor activity, as 
measured by photobeam breaks during a CPP trial (Otis and Mueller, 2011).  ***p < 
0.001 and **p < 0.01.  
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Neurobiological mechanisms of memory retrieval 
 The above results indicate that retrieval is dependent on β-AR activation in the 
central nervous system.  Our next goal was to determine the locus at which β-AR 
activation is required for retrieval.  We focused on three structures that are known to be 
important for the expression of learned behaviors:  PL-mPFC, basolateral amygdala 
(BLA), and dHipp. 
 
PL-mPFC involvement in memory retrieval 
 The PL-mPFC is necessary for the expression of learned fear.  Unit recordings in 
rats reveal that PL-mPFC pyramidal neurons become active during presentation of a CS 
that was previously paired with an aversive US (Burgos-Robles et al., 2009; Sotres-
Bayon et al., 2012).  This activity likely drives fear expression, as electrical stimulation 
of PL-mPFC augments cue-induced fear (Vidal-Gonzalez et al., 2006).  In contrast, 
inactivation of PL-mPFC prevents cue and context-induced fear expression, whereas PL-
mPFC inactivation does not prevent innate fear of a predator or fear of open spaces 
(Corcoran and Quirk, 2007).  Thus, PL-mPFC activity is involved in expression of 
learned, but not innate fear.  This dissociation allows for the conclusion that PL-mPFC 
activation is necessary for retrieval, not only behavioral expression, of fear memories.   
  PL-mPFC activity may also been critical for drug-associated memory retrieval.  
Exposure to a previously cocaine-paired cues leads to robust PL-mPFC immediate early 
gene expression (Miller and Marshall, 2004, 2005; Zavala et al., 2008) indicating that 
presentation of a cocaine-associated context may activate PL-mPFC.  Furthermore, drug-
induced CPP expression is blocked by PL-mPFC lesions (Isaac et al., 1989; Tzschentke 
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and Schmidt, 1999) or PL-mPFC DNA-methyltransferase inhibition (Han et al., 2010).  
Thus, expression of a drug-associated CPP memory depends on PL-mPFC activity.   
  PL-mPFC also regulates cue-induced drug seeking within the drug self-
administration paradigm.  Pharmacological inactivation of the PL-mPFC prevents cue 
and context-induced reinstatement of self-administration (McLaughlin and See, 2003; 
Fuchs et al., 2005; Hiranita et al., 2006; Ball and Slane, 2012).  Taken together, PL-
mPFC is important for behavioral expression of fear and drug-associated memories.   
   
BLA involvement in memory retrieval  
  The PL-mPFC has reciprocal connections with the basolateral amygdala (BLA) 
(Ishikawa and Nakamura, 2003; Gabbott et al., 2005), and BLA acts as a sensory 
interface for expression of learned fear (LeDoux, 2000).  Sensory inputs converge within 
BLA (LeDoux et al., 1990b; LeDoux et al., 1990a; Romanski et al., 1993) , and BLA 
neurons spike upon presentation of a shock-associated CS (CS
+
), but not upon 
presentation of a neutral CS (Quirk et al., 1995; Quirk et al., 1997).  Furthermore, 
disruption of BLA activity prevents cue-induced fear expression (Kim et al., 1993; Maren 
et al., 1996a; Lee et al., 2001).  Taken together, sensory inputs to the BLA allow cue-
induced fear expression.  BLA also receives input from the hippocampus (Canteras and 
Swanson, 1992), and this pathway may provide contextual information for fear 
expression (LeDoux, 2000).  In support of this, context-induced fear expression is 
dependent on BLA and dHipp activity (Kim and Fanselow, 1992; Phillips and LeDoux, 
1992; Helmstetter and Bellgowan, 1994; Maren et al., 1996b; Maren et al., 1997).  Thus, 
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BLA receives input regarding sensory and contextual information for the expression of 
learned fear.   
  The BLA is also important for the expression of drug-associated memories.  
Exposure to a previously cocaine-paired environment leads to robust BLA immediate 
early gene expression (Miller and Marshall, 2004, 2005).  Moreover, human studies 
reveal that drug-associated cue exposure increases amygdalar metabolic activity, and this 
activity correlates with reported drug cravings (Grant et al., 1996).  BLA lesions or 
inactivation prevent drug-induced CPP expression (Hiroi and White, 1991; Brown and 
Fibiger, 1993; McDonald et al., 2010) and sucrose-induced CPP expression (Everitt et al., 
1991).  Inactivation of the BLA protein kinase C (PKC) and protein synthesis also 
transiently impairs CPP expression (Lai et al., 2008).  In contrast, inhibition of BLA 
PKA, which is downstream of β-ARs (Pedarzani and Storm, 1993; Raman et al., 1996) 
has no effect on cocaine CPP expression (Lai et al., 2008).  Taken together, although the 
BLA is critical for drug-induced CPP expression, BLA β-AR dependent signaling is 
unlikely to mediate drug-induced CPP expression. 
  Evidence reveals that BLA activity is critical for retrieval of drug-associated self-
administration memories.  Exposure to cues associated with cocaine self-administration 
induces expression of BLA immediate early genes (Neisewander et al., 2000).  Moreover, 
BLA lesions or pharmacological inactivation prevent cue-induced reinstatement of drug 
seeking (Meil and See, 1997; Grimm and See, 2000; Fuchs and See, 2002; Kantak et al., 
2002; Yun and Fields, 2003; Fuchs et al., 2005).  In contrast, BLA inactivation has no 
effect on cocaine-induced reinstatement of cocaine seeking (Grimm and See, 2000).  
These data reveal that BLA activation is necessary for expression of cue-induced cocaine 
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seeking, and not simply expression of cocaine seeking.  Thus, the conclusion can be 
made that BLA activity is critical for retrieval of drug-associated memories in the self-
administration paradigm.   
 
dHipp involvement in memory retrieval 
 The dorsal hippocampus (dHipp) has reciprocal connections with PL-mPFC 
through its ventral subregion (vHipp) and through the nucleus reuniens of the thalamus 
(Hoover and Vertes, 2007; Vertes et al., 2007).  Moreover, the dHipp regulates 
expression of contextual fear memories.  Lesions or pharmacological inactivation of the 
dHipp prevents context-induced fear (Kim and Fanselow, 1992; Phillips and LeDoux, 
1992; Maren and Fanselow, 1997; Holt and Maren, 1999; Corcoran and Maren, 2001).  In 
contrast, dHipp lesions or inactivation do not impair discrete cue-induced fear (Kim and 
Fanselow, 1992; Corcoran and Maren, 2001).  Consistent with this, pharmacological or 
genetic disruption of dHipp β-AR signaling abolishes context, but not discrete cue-
induced fear expression (Murchison et al., 2004).  These data reveal that dHipp β-AR 
signaling is necessary for context-induced fear, not simply fear expression.  Thus, the 
conclusion can be made that the dHipp β-AR activation mediates contextual fear memory 
retrieval. 
  The dHipp is also important for expression of contextual drug-associated 
memories.  Immediate early genes are expressed within the dHipp following exposure to 
a previously drug-paired environment (Zhou and Zhu, 2006; Hearing et al., 2010).  
Moreover, lesions or pharmacological inactivation of dHipp prevents drug-induced CPP 
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expression (Meyers et al., 2003; Meyers et al., 2006; Zarrindast et al., 2006).  Thus, 
dHipp activity is critical for expression of drug-associated CPP memories. 
 Evidence reveals that dHipp activity is critical for retrieval of drug-associated 
self-administration memories.  Specifically, dHipp inactivation prevents context-induced 
reinstatement of cocaine self-administration (Fuchs et al., 2005).  In contrast, dHipp 
inactivation has no effect on discrete cue-induced reinstatement or cocaine-induced 
reinstatement of cocaine self-administration.  These data reveal that dHipp activation is 
necessary for context-induced cocaine seeking, and not simply expression of cocaine 
seeking.  Thus, the conclusion can be made that dHipp activation is required for retrieval 
of contextual drug-associated memories within the self-administration paradigm.   
 
Retrieval versus reconsolidation impairments: distinct or identical mechanisms? 
 The results described above reveal that PL-mPFC, BLA, and dHipp are involved 
in the expression of fear and drug-associated memories.  As described above, we found 
that disruption of central β-AR activation induces persistent impairments in retrieval of a 
cocaine-induced CPP memory (Otis and Mueller, 2011).  Thus, given the role of these 
structures in memory retrieval, we hypothesized that β-AR activity within PL-mPFC, 
BLA, or dHipp may be critical for maintaining cocaine-induced CPP memory retrieval.   
 When considering the involvement of a structure in the maintenance of memory 
retrieval, it is critical to also consider memory reconsolidation.  Specifically, any 
manipulations that induce persistent CPP disruption can be explained by 1) a persistent 
memory retrieval disruption, 2) a transient impairment in behavioral expression of the 
CPP along with blockade of memory reconsolidation, or 3) persistent impairment in CPP 
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expression due to effects that are unrelated to memory retrieval or reconsolidation (e.g., 
long-lasting motor impairments).  Moreover, whether the maintenance of retrieval 
requires distinct or identical mechanisms as stabilization of memory for reconsolidation 
had not been examined.  Thus, I next discuss the possible involvement of PL-mPFC, 
BLA, and dHipp in memory reconsolidation. 
 
Neurobiological mechanisms of memory reconsolidation 
PL-mPFC involvement in memory reconsolidation 
   Above I describe data supporting PL-mPFC involvement in expression of fear 
and drug-associated memories.  However, very few investigations have examined the role 
of PL-mPFC in memory reconsolidation.  PL-mPFC protein synthesis inhibition has been 
shown to impair the consolidation, but not reconsolidation, of a trace fear memory (Blum 
et al., 2006).  In contrast, PL-mPFC inactivation or α1-AR blockade impairs fear memory 
reconsolidation (Do Monte et al., 2013; Stern et al., 2013).  For drug-associated 
memories, one study revealed that PL-mPFC inactivation or protein synthesis inhibition 
following context re-exposure had no effect on subsequent context-induced cocaine self-
administration (Ramirez et al., 2009).  Taken together, although some studies support PL-
mPFC involvement in memory reconsolidation, this area of research has been mostly 
ignored. 
 
BLA involvement in memory reconsolidation 
  In contrast to PL-mPFC, many studies have revealed a critical role of the BLA for 
the stabilization of memory during reconsolidation.  This was first demonstrated with fear 
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conditioning, as BLA microinfusions of the protein synthesis inhibitor anisomycin 
immediately following CS
 
exposure impairs fear expression during a subsequent CS test 
(Nader et al., 2000).  Moreover, BLA anisomycin infusions also prevented reinstatement 
and spontaneous recovery of the fear memory (Duvarci and Nader, 2004), suggesting 
possible memory ablation.  Similarly, BLA β-AR blockade prevents the reconsolidation, 
but not consolidation, of an auditory fear memory (Debiec and Ledoux, 2004).  Thus, 
BLA β-AR signaling, including downstream PKA activation, may be critical for 
reconsolidation.  Indeed,  BLA PKA inhibition prevents fear memory reconsolidation, 
whereas BLA PKA activation enhances fear memory reconsolidation (Tronson et al., 
2006).  Amygdalar β-AR signaling may also be critical for reconsolidation of human 
memories.  Oral administration of the β-AR antagonist propranolol prevents 
reconsolidation of fear memories in humans (Kindt et al., 2009; Schwabe et al., 2013).  
Furthermore, experiments using fMRI reveal that disruption of reconsolidation in humans 
prevents the BLA from responding to presentation of the CS
 
(Agren et al., 2012).  Taken 
together, BLA β-AR signaling is critical for the reconsolidation of fear memories. 
  Evidence also reveals BLA involvement in reconsolidation of drug-associated 
memories.  Initial experiments demonstrated that ablation of BLA zif268 (an immediate 
early gene involved in synaptic plasticity) during cue presentation impairs subsequent 
cue-induced cocaine self-administration (Lee et al., 2005; Lee et al., 2006).  Moreover, 
disruption of amygdalar NMDAr (N-methyl D-aspartate receptor) activation also disrupts 
reconsolidation of cue-induced cocaine self-administration (Milton et al., 2008).  
Pharmacological or genetic disruption of BLA activity also impairs drug-associated CPP 
memory reconsolidation (Li et al., 2010; Theberge et al., 2010; Wu et al., 2011).  This 
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includes β-AR signaling, as inactivation of BLA β-ARs or downstream PKA prevents 
cocaine-induced CPP memory reconsolidation (Bernardi et al., 2009; Arguello et al., 
2013).  Taken together, BLA activity, including β-AR signaling, is critical for 
reconsolidation of drug-associated memories. 
  
dHipp involvement in memory reconsolidation 
 The dHipp is critical for reconsolidation of contextual memories.  In a contextual 
fear conditioning paradigm, dHipp protein synthesis inhibition following presentation of 
a fear-associated context disrupts subsequent context-induced fear (Debiec and Ledoux, 
2004; Lee et al., 2004).  In the self-administration paradigm, dHipp inactivation but not 
protein synthesis inhibition following context exposure disrupts subsequent context-
induced reinstatement (Ramirez et al., 2009).  Moreover, unilateral dHipp inactivation 
along with contralateral BLA protein synthesis inhibition following context exposure 
disrupts subsequent context-induced drug self-administration (Wells et al., 2011).  In 
contrast, either manipulation alone has no effect.  These data indicate that dHipp activity 
following presentation of contextual cues may be required for protein synthesis-
dependent reconsolidation processes in the BLA.  In the CPP paradigm, research reveals 
that disruption of dHipp protein synthesis or PKA following exposure to a morphine-
paired context
 
disrupts subsequent morphine-induced CPP expression (Milekic et al., 
2006; Taubenfeld et al., 2010).  As PKA and protein synthesis are downstream of β-AR 
signaling, these data indicate that reconsolidation of drug-associated CPP memories may 
require dHipp β-AR signaling. 
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Localizing the effects of β-AR blockade on cocaine CPP memory retrieval  
 The data above describe a critical role for PL-mPFC, BLA, and dHipp in retrieval 
and/or reconsolidation of fear and drug-associated memories.  We previously revealed 
that β-AR blockade induces persistent cocaine CPP memory retrieval impairments.  Thus, 
we next targeted PL-mPFC, BLA, and dHipp with β-AR antagonists before and after a 
CPP retrieval test to determine the effects of these manipulations on drug-associated 
memory retrieval and reconsolidation. 
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Otis, Dashew, and Mueller, 2013 
 We first determined the necessity of β-AR activation within the PL-mPFC for 
retrieval of a cocaine-induced CPP by administering β-AR antagonists before a CPP 
retrieval test.  Following conditioning, rats were given PL-mPFC microinfusions of saline 
or propranolol before the second CPP test.  Microinfusions of propranolol, but not saline, 
prevented CPP expression during the second test and during a subsequent microinfusion-
free test (see Figure 7B).  We next replicated these findings, but rats were given PL-
mPFC microinfusions of saline or the more selective β-AR antagonist nadolol before the 
first CPP test.  Rats treated with saline expressed a CPP for the previously cocaine-
associated chamber during all CPP tests, whereas rats treated with nadolol did not (see 
Figure 7C).  Moreover, PL-mPFC microinfusions of propranolol or nadolol did not affect 
locomotor activity, as measured by photobeam breaks during a CPP test (see Figure 7D 
and Figure 7E).  Thus, PL-mPFC microinfusions of β-AR antagonists induced a 
persistent impairment in expression of a cocaine-induced CPP without affecting 
locomotor activity. 
 We next determined the necessity of β-AR activation within the BLA for retrieval 
of a cocaine-induced CPP.  Following conditioning, rats were given BLA microinfusions 
of saline or propranolol before the second CPP test.  Microinfusions of propranolol had 
no effect on CPP during the second CPP test.  However, propranolol-treated rats 
expressed no CPP during the subsequent microinfusion-free test (see Figure 8B).  We 
next replicated these findings, but rats were given BLA microinfusions of saline or 
nadolol before the first CPP test.  Rats treated with saline expressed a CPP for the 
previously cocaine-associated chamber during all CPP tests, whereas rats treated with 
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nadolol only expressed a CPP during the first CPP test (see Figure 8C).  BLA 
microinfusions of propranolol or nadolol did not affect locomotor activity, as measured 
by photobeam breaks during a CPP test (see Figure 8D and Figure 8E).  Thus, BLA 
microinfusions of β-AR antagonists did not prevent initial expression of the CPP.  
However, BLA β-AR blockade did prevent CPP expression during subsequent 
microinfusion-free tests, indicating that BLA β-AR activation may be necessary for CPP 
memory reconsolidation. 
 We next determined if CPP expression deficits induced by PL-mPFC and BLA β-
AR blockade were due to disruption of memory reconsolidation.  First, following 
conditioning, rats were given PL-mPFC microinfusions of saline or nadolol immediately 
after the first CPP test.  Rats treated with either saline or nadolol expressed a CPP across 
all tests, indicating that PL-mPFC nadolol microinfusions had no effect on CPP 
expression (see Figure 9A).  Second, following conditioning rats were given BLA 
microinfusions of saline or nadolol immediately after the first CPP test.  Rats treated with 
saline expressed a CPP for the previously cocaine-associated chamber during all CPP 
tests, whereas rats treated with nadolol only expressed a CPP during the first CPP test 
(see Figure 9B).  Thus, β-AR blockade in BLA, but not PL-mPFC, prevented the 
reconsolidation of a cocaine CPP memory.  These results are consistent with data 
revealing that microinfusions of a β2-AR antagonist after a cocaine CPP test also 
attenuate subsequent CPP expression (Bernardi et al., 2009). 
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 We next confirmed that the observed findings were not due to nonspecific effects 
of PL-mPFC and BLA microinfusions on memory expression.  We already demonstrated 
that PL-mPFC or BLA propranolol and nadolol microinfusions do not affect locomotor 
activity.  Next, we evaluated the effects of PL-mPFC or BLA β-AR blockade in the 
absence of a CPP test.  Following conditioning, rats were given PL-mPFC or BLA 
microinfusions of nadolol in the absence of testing, following by a single microinfusion-
free CPP test the following day.  Rats that received microinfusions of saline or nadolol 
expressed an equivalent CPP during this test (see Figure 10), indicating that the effects of 
PL-mPFC and BLA β-AR blockade on CPP expression require memory reactivation (i.e., 
the CPP test).  Finally, we determined whether PL-mPFC or BLA β-AR blockade induces 
an affective state capable of altering CPP expression.  Rats received PL-mPFC or BLA 
microinfusions of nadolol in one chamber, and saline in another.  Following nadolol 
conditioning, rats were exposed to all chambers for a nadolol-induced CPP test.  Rats did 
not express a CPP or aversion for the previously nadolol-paired chamber (see Figure 11), 
indicating that nadolol did not induce an affective state capable of influencing CPP 
expression. 
 Our findings demonstrate that PL-mPFC β-AR activation during, but not after, a 
CPP test is critical for subsequent CPP expression.  Moreover, these effects were not due 
to reconsolidation blockade or nonspecific effects on behavioral expression of the CPP.  
These data lead to the conclusion that PL-mPFC β-AR activation maintains cocaine-
associated CPP memory retrieval.  Thus, we provide the first evidence that the 
maintenance of retrieval requires neural mechanisms that are completely distinct from 
those required for stabilization of memory during reconsolidation.  We have now further 
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examined the dissociation between retrieval deficits and reconsolidation blockade by 
evaluating the role of dHipp β-AR activation in retrieval and reconsolidation of a 
cocaine-induced CPP memory (Otis et al., 2014a). 
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Figures:  Otis, Dashew, and Mueller, 2013 
Figure 7 
 
Figure 7.  PL-mPFC β-AR blockade persistently impairs cocaine CPP memory retrieval.  
(A) Coronal drawings (bregma, +3.72) showing injector tip placements of PL-mPFC 
microinfusions.  (B) PL-mPFC microinfusions of propranolol, but not saline, before the 
second CPP trial persistently impair CPP expression.   (C) PL-mPFC microinfusions of 
nadolol, but not saline, before the first CPP trial induced a persistent deficit in CPP 
expression.  PL-mPFC microinfusions of (D) propranolol or (E) nadolol did not affect 
locomotor activity, as measured by photobeam breaks during a CPP trial (Otis et al., 
2013).  ***p < 0.001, **p < 0.01, and *p < 0.05. 
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Figure 8 
 
Figure 8.  BLA β-AR blockade does not block initial CPP memory retrieval.  (A) 
Coronal drawings (bregma, -2.76) showing injector tip placements of BLA 
microinfusions.  BLA microinfusions of (B) propranolol before the second CPP trial or 
(C) nadolol before the first CPP trial did not affect initial CPP expression, but prevented 
CPP expression during subsequent trials.  BLA microinfusions of (D) propranolol or (E) 
nadolol did not affect locomotor activity, as measured by photobeam breaks during a CPP 
trial (Otis et al., 2013).  ***p < 0.001, **p < 0.01, and *p < 0.05. 
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Figure 9 
 
Figure 9.  BLA but not PL-mPFC β-AR blockade impairs reconsolidation of a cocaine 
CPP memory.  (A) Coronal drawings (bregma, +3.72) showing injector tip placements of 
PL-mPFC microinfusions.  (B) PL-mPFC microinfusions of nadolol after a CPP trial did 
not prevent CPP expression during subsequent trials.  (C) Coronal drawings (bregma, -
2.76) showing injector tip placements of BLA microinfusions.  (D) BLA microinfusions 
of nadolol, but not saline, after a CPP trial prevent CPP expression during subsequent 
trials (Otis et al., 2013).  ***p < 0.001, **p < 0.01, and *p < 0.05. 
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Figure 10 
 
Figure 10.  PL-mPFC and BLA β-AR blockade in the absence of retrieval does not 
prevent CPP expression.  PL-mPFC (left) or BLA (right) microinfusions of nadolol do 
not prevent CPP expression during a CPP trial 24 hours later (Otis et al., 2013).  ***p < 
0.001 and **p < 0.01. 
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Figure 11 
 
Figure 11.  PL-mPFC and BLA β-AR blockade does not induce a CPP or aversion.  
Following conditioning with PL-mPFC or BLA microinfusions nadolol or saline, rats 
spent an equivalent amount of time within previously nadolol- and saline-paired 
chambers (Otis et al., 2013). 
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Otis, Fitzgerald, and Mueller, 2014a 
 We next determined the necessity of β-AR activation within the dHipp for 
retrieval of a cocaine-induced CPP by administering nadolol before a CPP retrieval test.  
Following conditioning, rats were given dHipp microinfusions of saline, a low dose of 
nadolol (1µg/µl) or a higher dose of nadolol (2µg/µl) before the first CPP test.  Rats 
treated with saline or the low dose of nadolol expressed a CPP for the previously cocaine-
associated chamber during all CPP tests, whereas rats treated with the high dose of 
nadolol did not (see Figure 12B).  To determine if this effect required the CPP test, or 
simply required exposure to the previously cocaine-paired chamber, we replicated the 
experiment but only exposed the rats to the previously cocaine-paired chamber following 
dHipp microinfusions.  Rats were then given daily CPP tests, during which previously 
saline-treated rats expressed a CPP, whereas previously nadolol-treated rats did not (see 
Figure 12C).  Thus, dHipp microinfusions of nadolol induced a persistent impairment in 
expression of a cocaine-induced CPP when administered before a CPP test or when 
administered before exposure to the previously cocaine-paired chamber. 
 We next determined the effects of dHipp β-AR blockade on subsequent cocaine-
induced reinstatement of the CPP.   Rats that were previously treated with dHipp nadolol 
or saline before the first CPP test (as described above; see Figure 12) were given a week 
break from testing.  Two final CPP tests were then given, during which no groups 
expressed a CPP.   The following day, rats previously treated with saline or the low dose 
of nadolol expressed cocaine-induced (5 mg/kg) reinstatement of the CPP, whereas rats 
previously treated with the high dose of nadolol did not (see Figure 13A).  We next 
replicated these findings, but administered a higher dose of cocaine during the cocaine-
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induced reinstatement test (10 mg/kg).  Consistent with the previous finding, rats 
previously treated with saline expressed cocaine-induced reinstatement of the CPP, 
whereas rats previously treated with the high dose of nadolol did not (see Figure 13B).  
Thus, dHipp nadolol-induced CPP expression deficits provided long-lasting protection 
against cocaine-induced reinstatement of the CPP.   
 We also investigated whether dHipp β-AR blockade-induced CPP expression and 
reinstatement deficits are due to disruption of memory reconsolidation.  Following 
conditioning, rats were given dHipp microinfusions of saline or nadolol immediately after 
the first CPP test.  Rats treated with saline expressed a CPP during the first, second, and 
third test whereas rats treated with nadolol expressed a CPP during the first, third, and 
fourth test (see Figure 14B).  Thus, although nadolol may have impaired CPP expression 
during the second CPP test, this effect was transient.  These findings indicate that CPP 
reconsolidation is not completely disrupted by dHipp β-AR blockade.  We next 
determined the effects of post-test dHipp β-AR blockade on subsequent cocaine-induced 
reinstatement of the CPP. Following a week break from testing, rats were given a final 
CPP trial, during which neither saline nor nadolol-treated rats expressed a CPP.  The 
following day, rats previously treated with saline or nadolol expressed cocaine-induced 
reinstatement of the CPP (see Figure 14C).  Thus, post-test nadolol microinfusions did 
not induce long-lasting CPP expression deficits and did not provide protection against 
cocaine-induced reinstatement of the CPP. 
 We next confirmed that the observed findings were not due to nonspecific effects 
of dHipp microinfusions on memory expression.  We first evaluated the effects of dHipp 
β-AR blockade in the absence of a CPP test.  Following conditioning, rats were given 
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dHipp microinfusions of nadolol in the absence of testing, following by a single 
microinfusion-free CPP test the following day.  Rats that received microinfusions of 
saline or nadolol expressed an equivalent CPP during this test (see Figure 15A).  Next, 
we determined whether dHipp β-AR blockade induces an affective state capable of 
influencing CPP expression.  Rats received dHipp microinfusions of nadolol in one 
chamber, and saline in another.  Following nadolol conditioning, rats were exposed to all 
chambers for a nadolol-induced CPP test.  Rats did not express a CPP or aversion for the 
previously nadolol-paired chamber (see Figure 15B), indicating that nadolol did not 
induce an affective state capable of influencing CPP expression.  Finally, dHipp 
microinfusions of nadolol did not affect locomotor activity, as measured by photobeam 
breaks during a CPP test (see Figure 15C).   
 Our findings demonstrate that dHipp β-AR activation during, but not after, a CPP 
test is critical for subsequent CPP expression.  Moreover, these effects were not due to 
reconsolidation blockade or nonspecific effects on behavioral expression of the CPP.  
Thus, the conclusion can be made that dHipp β-AR activation is necessary for 
maintaining cocaine-induced CPP memory retrieval. 
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Figures:  Otis, Fitzgerald, and Mueller, 2014 
Figure 12 
 
Figure 12.  dHipp β-AR blockade persistently impairs cocaine CPP memory retrieval.  
(A) Coronal drawings (bregma, -3.24 mm) showing injector tip placements of dHipp 
microinfusions.  (B) dHipp microinfusions of a high dose of nadolol, but not a low dose 
or saline, before the first CPP trial persistently impair CPP expression.  (C) dHipp 
microinfusions of nadolol, but not saline, before exposure to the previously cocaine-
paired chamber only prevented CPP expression during subsequent CPP trials (Otis et al., 
2014a).  ***p < 0.001, **p < 0.01, and *p < 0.05. 
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Figure 13 
 
Figure 13.  Retrieval impairments induced by dHipp β-AR blockade prevent cocaine-
induced reinstatement.  Rats treated with saline or nadolol before an initial CPP trial 
expressed no CPP during the final CPP extinction trials.  Following injections of a (A) 
low or (B) high dose of cocaine, rats previously treated with dHipp microinfusions of 
saline or the low dose of nadolol, but not the high dose of nadolol, expressed cocaine-
induced reinstatement of the CPP (Otis et al., 2014a).  ***p < 0.001 and *p < 0.05. 
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Figure 14 
 
Figure 14.  dHipp β-AR blockade does not abolish CPP memory reconsolidation.  (A) 
Coronal drawings (bregma, -3.24 mm) showing injector tip placements of dHipp 
microinfusions.  (B) dHipp microinfusions of a nadolol did not prevent rats from 
expressing a CPP during subsequent trials.  (C) Rats treated with saline or nadolol 
expressed no CPP during the final CPP extinction trial.  Rats previously treated with 
dHipp microinfusions of saline or nadolol after the first CPP trial expressed cocaine-
induced reinstatement of the CPP (Otis et al., 2014a). ***p < 0.001, **p < 0.01, and *p < 
0.05. 
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Figure 15 
 
Figure 15.  Effects of dHipp nadolol microinfusions on CPP expression are not due to 
nonspecific effects.  (A) dHipp microinfusions of nadolol did not prevent rats from 
expressing a CPP 24 hours later.  (B) Following conditioning with dHipp microinfusions 
of nadolol or saline, rats spent an equivalent amount of time within previously nadolol- 
and saline-paired chambers.  (C) dHipp microinfusions of nadolol not affect locomotor 
activity, as measured by photobeam breaks during a CPP trial (Otis et al., 2014a).  ***p < 
0.001, **p < 0.01, and *p < 0.05. 
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Proposed model of drug-associated memory retrieval 
  The experiments described throughout this dissertation reveal some basic neural 
mechanisms required for memory retrieval.  Next, I use these and other studies to 
illustrate a likely system that is required for (and maintains) drug-associated memory 
retrieval (see Figure 16).   
  PL-mPFC is necessary for retrieval of learned fear (Corcoran and Quirk, 2007) 
and drug-associated memories (Otis et al., 2013).  Relapse to drug seeking involves 
perturbations in particular PL-mPFC outputs which synapse onto nucleus accumbens core 
(NAcc) medium spiny neurons (Kalivas et al., 2005).  NAcc glutamatergic receptor 
activity is critical for reinstatement of drug seeking (Fuchs et al., 2004; LaLumiere and 
Kalivas, 2008), and NAcc extracellular glutamate levels increase during reinstatement 
(Baker et al., 2003; McFarland et al., 2003).  Moreover, PL-mPFC microinfusions of 
brain-derived neurotrophic factor (BDNF) or GABA receptor agonists prevent 
reinstatement and prevent the rise in NAcc extracellular glutamate (McFarland et al., 
2003; Berglind et al., 2009).  Thus, PL-mPFC likely provides glutamatergic input to the 
NAcc, which drives behavioral expression of drug seeking.   
  The PL-mPFC has reciprocal projections with the BLA (Ishikawa and Nakamura, 
2003; Gabbott et al., 2005), a structure that is also critical for drug-associated memory 
retrieval (Grimm and See, 2000).  Moreover, evidence reveals that the BLA may activate 
PL-mPFC for retrieval.    First, disconnection of these structures via contralateral 
inactivation prevents cue-induced reinstatement of cocaine seeking (Mashhoon et al., 
2010).  Second, PL-mPFC projecting BLA neurons express immediate early genes 
following exposure to a previously cocaine-associated environment (Miller and Marshall, 
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2005).  In contrast, although some PL-mPFC neurons also express more immediate early 
genes upon context exposure, those neurons do not project back to the BLA (Miller and 
Marshall, 2005).  Taken together, BLA neurons drive PL-mPFC activation for drug-
associated memory retrieval. 
  The dHipp provides input to the BLA and has indirect projections to the PL-
mPFC through its ventral subregion and through the nucleus reuniens of the thalamus 
(Hoover and Vertes, 2007; Vertes et al., 2007).  Considering the role of the dHipp in 
contextual fear and drug-associated memory retrieval (Corcoran and Maren, 2001; Fuchs 
et al., 2005), dHipp likely provides contextual information to BLA and PL-mPFC for 
memory retrieval.   
  Finally, nuclei of noradrenergic neurons, such as the locus coeruleus (LC) and 
nucleus tractus solitarius (NTS) reside within the brainstem.  Our data suggest that 
noradrenergic neurons secrete norepinephrine within PL-mPFC and dHipp to support 
drug-associated memory retrieval.   In support of this, presentation of salient cues leads to 
norepinephrine release (Cassens et al., 1980).  Moreover, artificial enhancement of NE 
release via direct stimulation of LC neurons enhances behavioral expression of memory 
(Sara and Devauges, 1988), an effect that is dependent on β-AR activation (Devauges and 
Sara, 1991).  NE release is known to activate PL-mPFC and dHipp β-ARs (Pedarzani and 
Storm, 1993; Otis et al., 2013), and we found that this activation is critical for cocaine-
induced CPP memory retrieval (Otis et al., 2013; Otis et al., 2014a).  Thus, brainstem 
noradrenergic neurons become active following presentation of salient cues, and this 
activity allows memory retrieval.  Interestingly, although most memory studies have 
focused on LC neurons, some data hint that NTS neurons may be critical for drug-
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associated memory retrieval.  Specifically, data reveal that genetic deletion of 
norepinephrine, via knockout of norepinephrine-synthesizing enzyme dopamine β-
hydroxylase, prevents drug-induced CPP expression (Jasmin et al., 2006; Olson et al., 
2006).  Moreover, restoration of norepinephrine within the NTS rescues these 
impairments (Olson et al., 2006).  Thus, norepinephrine released from the NTS may be 
critical for drug-associated memory retrieval.  However, further investigations must be 
completed to confirm this hypothesis. 
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Figure 16 
 
Figure 16.  Proposed model of drug-associated memory retrieval.  Brainstem nuclei 
(LC/NTS) release norepinephrine into forebrain structures (dHipp, PL-mPFC). These 
structures, including the BLA, interact to promote cocaine-associated memory expression 
through NAcc-projecting PL-mPFC neurons. LC, locus coeruleus; NTS, nucleus tractus 
solitarius; vHipp, ventral hippocampus; dHipp, dorsal hippocampus; PL, prelimbic 
medial prefrontal cortex; NAcc, nucleus accumbens core. 
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Prelimbic β-AR activation enhances synaptic plasticity and intrinsic excitability 
 The data described demonstrate that PL-mPFC input, including noradrenergic 
input for β-AR activation, is required for memory retrieval.  However, the mechanism by 
which β-AR activation maintains retrieval is unknown.  Next, I describe research 
regarding the effects of β-AR activation on synaptic and intrinsic neuronal activity.  
Moreover, I use this research to describe a possible mechanism by which β-AR activity 
maintains retrieval. 
 
β-AR activation enhances synaptic plasticity  
 Synaptic strength is modified by the strength and timing of presynaptic inputs  
(Bliss and Lomo, 1973; Levy and Steward, 1979; Malenka and Nicoll, 1999).  This 
synaptic plasticity is a likely mechanism of learning, as learning is associated with 
synaptic plasticity within brain regions that are required for that learning (McKernan and 
Shinnick-Gallagher, 1997; Rogan et al., 1997; Whitlock et al., 2006).  Moreover, 
mechanisms that are required for synaptic plasticity, including glutamate receptor 
activity, are also important for learning (Morris et al., 1986; Artola and Singer, 1987; 
Kleinschmidt et al., 1987; Miserendino et al., 1990; Tsien et al., 1996; Malenka and 
Nicoll, 1999; Tang et al., 1999).  Thus, synaptic plasticity is a likely mechanism of 
learning and memory.   
 Synaptic plasticity is regulated by β-AR activation, although the exact role of β-
AR activity in synaptic plasticity varies depending on the brain region (O'Dell et al., 
2010).  Studies reveal that NE or β-AR agonists enhance electrically-evoked long-term 
potentiation (LTP) at hippocampal mossy fiber synapses (Hopkins and Johnston, 1984).  
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Moreover, NE and β-AR agonists enhance LTP at these synapses via both presynaptic 
and postsynaptic mechanisms (Hopkins and Johnston, 1988; Huang and Kandel, 1996).  
β-AR agonists also promote spike-timing dependent plasticity (STDP) at mPFC 
pyramidal neuron synapses (Zaitsev and Anwyl, 2012), although the exact mechanism by 
which β-AR activation facilitates mPFC plasticity is unclear.  Recently, studies revealed 
that mPFC β-AR activation increases evoked excitatory postsynaptic currents (eEPSCs) 
by increasing presynaptic neurotransmitter release and by enhancing NMDAr channel 
conductance (Huang and Hsu, 2006; Zaitsev and Anwyl, 2012).  Taken together, NE-
induced β-AR activation may facilitate mPFC synaptic plasticity by 1) increasing 
presynaptic glutamate release and 2) by enhancing postsynaptic NMDAr channel 
conductance. 
 
β-AR activation enhances intrinsic excitability 
 Intrinsic excitability can be defined as the electrical properties of a neuronal 
membrane that are independent of synaptic activity.  For example, EPSP propagation and 
properties of the action potential (e.g., threshold, amplitude, width, and adaptation) are 
not dependent on synaptic input.  Intrinsic excitability is modulated by experience 
(Woody and Black-Cleworth, 1973; Alkon, 1974; Disterhoft et al., 1986; Moyer et al., 
1996) and by neuromodulators, including NE (Madison and Nicoll, 1982, 1986b, a; 
Pedarzani and Storm, 1993).  In hippocampal and infralimbic mPFC pyramidal neurons, 
NE reduces the slow afterhyperpolarization (sAHP) and limits spike frequency 
adaptation, effects that are blocked by β-AR antagonists (Madison and Nicoll, 1982, 
1986a, b; Pedarzani and Storm, 1993; Mueller et al., 2008).  Thus, β-AR activation 
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enhances the intrinsic excitability of hippocampal and infralimbic mPFC pyramidal 
neurons.  However, the effect of β-AR activation on the excitability of PL-mPFC 
pyramidal and GABAergic neurons was unknown. 
 Using patch-clamp electrophysiology, we determined the effects of β-AR 
activation on PL-mPFC pyramidal cell and GABAergic interneuron excitability.  
Pyramidal neurons were identified based on the presence of an apical dendrite, and this 
morphology was subsequently confirmed via immunohistochemistry (see Figure 17A).  
Following baseline recordings, action potentials were evoked by brief current pulses (see 
Figure 17B).  Application of NE increased the number of evoked action potentials (see 
Figure 17C).  Moreover, NE, caused membrane depolarization, decreased rheobase, and 
reduced action potential latency (see Table 2), all of which indicate enhanced intrinsic 
excitability. These changes were not present in neurons that were treated with both 
propranolol and NE, indicating that NE increases the intrinsic excitability of PL-mPFC 
pyramidal neurons via β-AR activation.   Finally, although NE had no effect on the fast 
AHP (fAHP) in pyramidal neurons, NE transformed the sAHP to a slow 
afterdepolarization (see Figure 17D). As the sAHP limits AP frequency (Wu et al., 2004), 
reversal of the sAHP is a likely mechanism by which β-AR activation enhances the 
number of evoked action potentials. Consistent with this, propranolol prevented NE from 
reversing the sAHP (see Figure 17E). 
 Although the primary output neurons of the PL-mPFC are pyramidal neurons, 
these neurons function within a network of GABAergic interneurons.  Thus, we next 
evaluated the effects of β-AR activation on the intrinsic excitability of GABAergic 
interneurons.   GABAergic interneurons were identified by morphology (lack of apical 
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dendrite), electrophysiological characteristics (see Table 1), and by streptavidin and 
GAD67 co-immunoreactivity (see Figure 18A).  Similar to pyramidal neurons, 
application of NE increased the number of evoked action potentials (see Figure 18C).  
Moreover, NE caused membrane depolarization, decreased rheobase, and reduced action 
potential latency (see Table 3), all of which indicate enhanced intrinsic excitability. These 
changes were not present in GABAergic interneurons that were treated with both 
propranolol and NE, indicating that NE increases the intrinsic excitability of these 
neurons via β-AR activation.   Unlike pyramidal neurons, NE had no effect on the sAHP 
of GABAergic interneurons (see Table 3).  This finding is consistent with data revealing 
that these neurons lack a sAHP (McCormick et al., 1985).  In contrast, NE reduced the 
fAHP, (see Figure 17D), and this effect was blocked by co-application of propranolol 
(see Figure 17E).  Thus, β-AR activation may enhance the intrinsic excitability of 
GABAergic interneurons by reducing the fAHP.  
  The data described reveal that β-AR activation strengthens synaptic activity 
within the mPFC (e.g., STDP and NMDAr currents) and enhances intrinsic excitability of 
PL-mPFC pyramidal and GABAergic interneurons.  Below I describe a possible 
mechanism by which these changes may maintain memory retrieval.
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Table 1 
Neuron RN (MΩ) Vm (mV) APwidth (ms) APamp (mV) fAHP (mV) sAHP (mV) 
Pyramidal 125 ± 11 -69 ± 2 2.6 ± 0.2 67 ± 2 -6.4 ± 0.6 -0.7 ± 0.1 
GABA 310 ± 6*** -66 ± 1 2.1 ± 0.1** 61 ± 2* -13.6 ±0.8*** -0.0 ± 0.1*** 
 
Table 1.  Basic membrane properties of PL-mPFC pyramidal and GABA neurons.  
PL-mPFC GABAergic neurons had larger input resistance and fAHP, but smaller AP 
width and sAHP as compared with pyramidal neurons.  APwidth, action potential width; 
APamp, action potential amplitude; RN, input resistance; Vm, Resting membrane potential; 
fAHP, fast afterhyperpolarization; sAHP, slow afterhyperpolarization.  ***p < 0.001 and 
*p < 0.05 as compared with pyramidal neurons (Otis et al., 2013).
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Figure 17 
 
 
 
Figure 17.  β-AR blockade prevents NE from enhancing intrinsic excitability of PL-
mPFC pyramidal neurons.  (A) Example photomicrograph of biocytin-filled PL-mPFC 
pyramidal neuron.  (B)  Example traces revealing that NE increased the number of 
evoked action potentials.  (C) Grouped data reveal that NE-induced enhancement of 
evoked action potentials was blocked by propranolol.  (D) Example traces revealing that 
NE decreased the sAHP.  (E) Grouped data reveal that NE-induced reduction of sAHP 
was blocked by propranolol (Otis et al., 2013).  Prop, propranolol; *p < 0.05. 
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Figure 18 
 
 
 
Figure 18.  β-AR blockade prevents norepinephrine from enhancing intrinsic excitability 
of PL-mPFC GABAergic interneurons.   (A) Example photomicrograph of biocytin-filled 
PL-mPFC GABAergic interneuron.  (B)  Example traces revealing that NE increased the 
number of evoked action potentials.  (C) Grouped data reveal that NE-induced 
enhancement of evoked action potentials was attenuated by propranolol.  (D) Example 
traces revealing that NE decreased the fAHP.  (E) Grouped data reveal that NE-induced 
reduction of fAHP was blocked by propranolol (Otis et al., 2013).  Prop, propranolol; **p 
< 0.01. 
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Table 2 
Drug Time RN (MΩ) Vm (mV) Rheo (pA) APthresh (mV) APlatency (ms) fAHP (mV) sAHP (mV) 
NE 
Pre 121± 24 -70 ± 3 223 ± 75 -40 ± 2 118 ± 18 -7.3 ± 0.7 -0.5 ± 0.2 
Post 124 ± 30 -65 ± 3** 173 ± 74** -39 ± 1 53 ± 8** -7.7 ± 1.1 0.3 ± 0.2* 
Prop  
+ NE 
Pre 132 ± 13 -69 ± 4 93 ± 11 -41 ± 5 130 ± 28 -5.6 ± 1.3 -0.9 ± 0.3 
Post 149 ± 12 -68 ± 4 88 ± 18 -41 ± 4 102 ± 29 -4.5 ± 1.6 -0.9 ± 0.3 
 
Table 2.  Effects of NE and propranolol on intrinsic excitability of PL-mPFC 
pyramidal neurons.  NE, norepinephrine; Prop, propranolol; RN, input resistance;  Vm, 
resting membrane potential; Rheo, rheobase; APthresh, action potential threshold; APlatency, 
action potential latency; fAHP, fast afterhyperpolarization; sAHP, slow 
afterhyperpolarization.  *p < 0.05, **p < 0.01 as compared with before NE application 
(Otis et al., 2013). 
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Table 3 
Drug Time RN (MΩ) Vm (mV) Rheo (pA) APthresh (mV) APlatency (ms) fAHP (mV) sAHP (mV) 
NE 
Pre 285 ± 56 -65 ± 2 74 ± 15 -42 ± 2 127 ± 35 -11 ± 0.9 0.0 ± 0.1 
Post 231 ± 39 -60 ± 2** 31 ± 9** -44 ± 2 32 ± 10** -6.1 ±1.6** 0.0 ± 0.2 
Prop  
+ NE 
Pre 333 ± 52 -69 ± 3 58 ± 9 -44 ± 2 148 ± 44 -14.1 ± 1.0 -0.2 ± 0.2 
Post 365 ± 53 -69 ± 3 39 ± 9* -46 ± 2 83 ± 23 -13.1 ± 1.7 0.3 ± 0.4 
 
Table 3.  Effects of NE and propranolol on intrinsic excitability of PL-mPFC 
GABAergic interneurons.  NE, norepinephrine; Prop, propranolol; RN, input resistance;  
Vm, resting membrane potential; Rheo, rheobase; APthresh, action potential threshold; 
APlatency, action potential latency; fAHP, fast afterhyperpolarization; sAHP, slow 
afterhyperpolarization.  *p < 0.05, **p < 0.01 as compared with before NE application 
(Otis et al., 2013). 
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Proposed mechanism of memory retrieval deficits:  PL-mPFC synaptic depression  
 Salient cue exposure induces NE release, leading to β-AR activation (Cassens et 
al., 1980).  Thus, cocaine- or fear-associated cue exposure is likely to induce β-AR 
activation, which is known to increase synaptic currents and intrinsic excitability of PL-
mPFC neurons (Ji et al., 2008; Otis et al., 2013).  In support of this, exposure to a fear-
associated CS increases the firing rate of PL-mPFC neurons (Burgos-Robles et al., 2009; 
Sotres-Bayon et al., 2012), whereas spontaneous PL-mPFC activity is reduced by 
systemic injections of propranolol (Rodriguez-Romaguera et al., 2009).  In addition to 
noradrenergic potentiation of PL-mPFC neurons, PL-mPFC activity during cue 
presentation is dependent on glutamatergic input from the hippocampus and amygdala 
(Sotres-Bayon et al., 2012).  Taken together, PL-mPFC neurons are more responsive to 
glutamate input during retrieval (due to NE-induced enhancement of EPSCs and intrinsic 
excitability), increasing the likelihood that EPSCs will induce action potentials.  On the 
other hand, presynaptic input in the absence of synchronous postsynaptic action 
potentials can induce synaptic depression (Froemke and Dan, 2002; Froemke et al., 
2005).  Thus, PL-mPFC β-AR activation may maintain synchronous presynaptic and 
postsynaptic activity during retrieval, whereas disruption of this synchrony likely 
weakens PL-mPFC synapses.  Consistent with this hypothesis, NE prevents spike-timing 
dependent depression (STDD) at cortical synapses (Salgado et al., 2012).  Thus, β-AR 
blockade during retrieval may induce PL-mPFC synaptic depression, resulting in long-
term retrieval impairments.  
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Dissertation Goal and Aims 
 Abnormally strong memories underlie drug addiction and fear disorders such as 
PTSD.  Preventing retrieval of these memories would alleviate these disorders.  Above, I 
describe three publications revealing that cocaine-associated CPP memory retrieval is 
susceptible to persistent disruption (Otis and Mueller, 2011; Otis et al., 2013; Otis et al., 
2014a).  Moreover, recent studies using humans reveal that β-AR blockade can induce 
persistent disruption of visual and emotional memory retrieval (Kroes et al, 2010; Kroes 
et al., 2012 SfN Abstracts).  Although the human studies do not completely rule out 
memory reconsolidation effects, such experiments indicate that β-AR blockade-induced 
memory retrieval impairments may not be limited to cocaine CPP memories.  Thus, the 
goal of this dissertation is to characterize the mechanism of memory retrieval deficits and 
determine whether retrieval of other memories is maintained by β-AR activity.  This will 
be accomplished in the two following aims. 
 
Aim 1:  Determine whether β-AR activation is a fundamental mechanism for 
maintenance of memory retrieval.  Here I focus on the necessity of PL-mPFC β-AR 
activity for maintaining retrieval of fear memories.  Specifically, I determine the effects 
of PL-mPFC β-AR blockade on retrieval of 1) a contextual fear memory, 2) a delay fear 
memory, and 3) a trace fear memory.   
 
Aim 2:  Evaluate the underlying mechanisms of memory retrieval impairments.  
Next, I determined the underlying mechanism by which memory retrieval impairments 
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occur.  Using patch-clamp electrophysiology, I characterized the intrinsic and synaptic 
properties of PL-mPFC neurons from adult rats that have retrieval impairments as 
compared with rats from appropriate control groups.  
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Methods 
Subjects 
Adult male Long-Evans rats weighing 300-325 grams were housed individually in 
clear plastic cages with access to standard laboratory rat chow (Harlan Laboratories) and 
water ad libitum unless otherwise noted.  Rats were maintained on a 14 hour light/10 
hour dark cycle (lights on at 7am) and were weighed and handled daily.  All experimental 
protocols were approved by the Institutional Animal Care and Use Committee at the 
University of Wisconsin-Milwaukee in accordance with National Institutes of Health 
guidelines. 
 
Cannula surgery 
PL-mPFC cannula surgeries were performed to allow PL-mPFC β-AR blockade.  
Rats were anesthetized with ketamine/xylazine (90 mg/kg, 10.5 mg/kg, i.p.).  Following 
anesthetization, double-barrel guide cannula (26 gauge; Plastics One, Roanoke, VA) were 
implanted within PL-mPFC (AP, +2.8; ML, ±0.6; DV, -2.9 mm relative to bregma).  
Cannula were fixed into place with 3 stainless steel skull screws and grip cement.  
Following surgery, rats were treated with an antibiotic (penicillin g procaine, 75,000 units 
in 0.25 ml, s.c.) and an analgesic (carprofen, 5.0 mg in 0.1 ml, s.c.).  Rats were given a 
minimum of 7 days for recovery following surgeries, during which behavioral 
experiments were not conducted.  Stylets remained within the guide cannula following 
surgery to maintain patency until microinfusions were performed.   
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Drugs and microinfusions 
Cocaine HCl (National Institute of Drug Abuse) was dissolved in sterile 0.9% 
saline and was systemically administered (10 mg / kg).  PL-mPFC β-AR blockade was 
induced via infusions of nadolol (1.2 µg / 0.6 µl saline; Sigma-Aldrich) at 0.3 µl / side 
over a 2 minute time period.  Microinfusion injectors were left in place for a minimum of 
1 minute following microinfusions. 
 
Fear conditioning chamber 
Fear conditioning was conducted within sound-attenuating chambers (MED 
Associates, St. Albans,VT) containing an electrifiable floor of rods (23 4.8-mm stainless 
steel bars spaced 1.3 cm apart),  clear Plexiglas (front/back) and aluminum (side) walls, a 
tone generator, and a house light.  The conditioning chamber was cleaned with 10% 
ethanol before conditioning.  An alternative context was used for delay and trace fear 
testing, and this context was equipped with infrared lighting, smooth, black fiberglass 
floors, and striped black and white Plexiglas walls (front/back).  The alternative context 
was cleaned with ammonium hydroxide before each test.   
 
Place conditioning apparatus 
 Place conditioning and testing were conducted in a 3-chamber apparatus 
containing 2 distinguishable conditioning chambers (13” x 9” x 11.5”) separated by a 
smaller center chamber (6” x 7” x 11.5”).  One of the conditioning chambers contains 
wire mesh flooring with white walls, whereas the other conditioning chamber has gold-
grated flooring with a black wall.  The smaller center chamber has aluminum sheeting as 
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flooring and white walls.  Each of the larger chambers contains two infrared photobeams 
separated by 3”. If the beam furthest from the center chamber was broken, then the rat 
was determined to be in the larger chamber.  If only the beam closest to the center 
chamber was broken, then the rat was determined to be in the center chamber.   
 
Methods:  Aim 1 
 Aim 1 was completed to determine whether β-AR activation is a fundamental 
mechanism of memory retrieval.  
 
Aim 1a:  Contextual fear conditioning 
Rats underwent foreground contextual fear conditioning, during which the 
conditioning context was paired with an aversive foot shock.  Rats were exposed to the 
conditioning context for a 6 minute baseline period, followed by 4 presentations of a 1 
second shock (0.8 mA).  The shocks were separated by a 240 ± 20 second inter trial 
interval followed by a 4 minute post-conditioning period. 
Rats were next given daily context fear retrieval tests.  To determine the necessity 
of PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PL-
mPFC microinfusions of saline or nadolol were administered.  Fifteen minutes later rats 
were given a 3 minute context fear memory retrieval test within the original conditioning 
chamber (Corcoran and Quirk, 2007).  Following the microinfusion test, daily infusion-
free tests continued to determine the long-lasting effects of β-AR blockade on context 
fear memory retrieval. Following multiple unreinforced retrieval tests, rats undergo 
extinction (Quirk and Mueller, 2008), allowing us to assess reinstatement of the fear 
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memory.  To induce reinstatement, rats were given a normal context retrieval test, but at 
the end of the test a 1 second shock (0.8 mA) was presented.  The rats were then tested 
for reinstatement of fear the following day by giving an identical context test in the 
absence of shock. 
 
Aim 1b: Delay fear conditioning 
 Rats were trained to associate a white noise CS with a 1 second shock UCS.  
Specifically, rats were exposed to the training context for a 6 minute baseline period, 
followed by 4 pairings of the CS and UCS.  The white noise (72 dB) CS was played for 
10 seconds and co-terminated with the 1 second shock UCS (1 mA).  The CS-UCS 
pairings were presented with a 240 ± 20 second inter trial interval followed by a 4 minute 
post-conditioning period.   
Rats were next given daily delay fear retrieval tests.  To determine the necessity 
of PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PL-
mPFC microinfusions of saline or nadolol were administered.  Fifteen minutes later rats 
were exposed to the alternative context.  Following a 2 minute baseline period, the CS 
was presented for 2 minutes, followed by a 2 minute post CS period.  Freezing during and 
after the CS was quantified separately.  Following the microinfusion test, daily infusion-
free tests continued to determine the long-lasting effects of β-AR blockade on delay fear 
memory retrieval.  Finally, following extinction of delay fear rats were represented with 
the shock UCS (1s; 1mA) immediately following a normal delay fear test.  The rats were 
then tested for reinstatement of fear the following day by giving an identical retrieval test 
in the absence of shock.   
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Aim 1c: Trace fear conditioning 
 Rats learned to predict the presentation of an aversive footshock UCS following 
presentation of a tone CS.  Rats were exposed to the training context for a 6 minute 
baseline period, followed by 6 pairings of the CS and UCS.  Specifically, a white noise 
(72 dB) CS was presented for 10 seconds, followed by a 20 second interval, and finally a 
1 second shock UCS (1 mA).  The CS-UCS pairings were presented with a 240 ± 20 
second inter trial interval followed by a 4 minute post-conditioning period.   
Rats were next given daily trace fear retrieval tests.  To determine the necessity of 
PL-mPFC β-AR activation for memory retrieval, 1 or 30 days after conditioning PL-
mPFC microinfusions of saline or nadolol were administered.  Fifteen minutes later rats 
were exposed to the alternative context.  Following a 2 minute baseline period, the CS 
was presented for 2 minutes, followed by a 2 minute post CS period.  Freezing during the 
and after the CS was quantified separately.  Following the microinfusion test, daily 
infusion-free tests continued to determine the long-lasting effects of β-AR blockade on 
delay fear memory retrieval.  Finally, following extinction of trace fear rats were 
represented with the shock UCS (1s; 1mA) immediately following a normal trace fear 
test.  The rats were then tested for reinstatement of fear the following day by giving an 
identical retrieval test in the absence of shock.   
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Figure 19 
 
 
Figure 19.  Summary of behavioral experiments as described in aim 1.  Arrows represent 
microinfusions 15 minutes before behavioral testing. 
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Methods:  Aim 2 
Aim 2 was completed to determine the mechanism of memory retrieval 
impairments.  
 
Place conditioning 
 Baseline preferences were assessed by placing the rats into the center of the CPP 
apparatus with full access to all 3 chambers 15 minutes.  We previously demonstrated 
that rats spend equivalent time within the larger conditioning chambers before 
conditioning (Otis and Mueller, 2011). Thus, following baseline testing rats were 
conditioned to associate one chamber, but not another, with cocaine in a pseudorandom 
and counterbalanced fashion over 8 days.  Injections of saline or cocaine were 
administered immediately before each 20 minute conditioning session, during which rats 
were confined to the appropriate chamber.   
 
Experimental manipulations 
 Following conditioning, rats were given systemic injections of saline (CPP-S) or 
propranolol (CPP-P) as previously described (Otis and Mueller, 2011).  Twenty minutes 
later each rat was given a CPP memory retrieval test, during which full access to all 3 
chambers was allowed for 15 minutes.  A final control group of rats received post-test 
propranolol injections (CPP-PP), allowing us to determine assess the effects of 
propranolol on CPP memory reconsolidation.  The next day, rats were given a second 
CPP retrieval test in the absence of saline or propranolol injections.   To determine the 
mechanism of propranolol-induced memory retrieval impairments, rats were sacrificed 
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for electrophysiological recordings 1 hour following the second memory retrieval test 
(Pattwell et al., 2012).  
 
Patch-clamp electrophysiology 
Patch-clamp recordings were established as previously described (Otis et al., 
2013; Otis et al., 2014b).  Rats aged 3-6 months were anesthetized with pentobarbital, 
and brains were quickly removed and transferred into ice-cold (0-2˚C) oxygenated (95% 
O2 / 5% CO2) artificial cerebral spinal fluid (aCSF) composed of the following (in mM): 
124 NaCl, 2.8 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, and 20 dextrose.  
Coronal slices 300 µm thick containing prefrontal cortex were taken using a vibratome 
(Leica VT1200).  Slices recovered in warm aCSF (32˚C) for approximately 30 minutes, 
followed by incubation in room temperature aCSF for 0.5-8 hours.  Next, slices were 
transferred into a recording chamber and continuously perfused with aCSF (2 ml / min).  
PL-mPFC layer V neurons were visualized with differential interference contrast using a 
60X water-immersion lens mounted on an upright Eclipse FN1 microscope (Nikon 
Instruments).  Pyramidal neurons were identified based on the presence of an apical 
dendrite, and GABAergic interneurons were identified based on the lack of an apical 
dendrite (Otis et al., 2013).  Whole cell recordings of pyramidal neurons were then 
obtained using borosilicate glass pipettes with low resistance tips (2-4 ΜΩ) containing a 
potassium gluconate-based internal solution composed of the following (in mM): 110 K-
gluconate, 20KCl, 10 HEPES, 2 MgCl2, 2 ATP, 0.3 GTP, 10 phosphocreatine, 0.2% 
biocytin, 7.3 pH, 280 mOsm.  Synaptic recordings were obtained with voltage clamp, 
whereas intrinsic excitability recordings were obtained with current clamp using the 
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MultiClamp 700B amplifier connected to a Digidata 1440A digitizer (Molecular 
Devices).  The liquid-liquid junction potential (measured as 13 mV) was compensated for 
throughout all recordings. All electrophysiological data were analyzed using Clampfit 
(Molecular Devices). 
The intrinsic excitability of PL-mPFC pyramidal neurons was investigated by 
recording under current clamp.  Neurons were held at -70 mV via direct somatic 
stimulation to control for differences in resting membrane potential.   Next, a series of 1 
second depolarizing steps were applied (0 to 500 pA; 50 pA steps), and the number of 
evoked action potentials was recorded.  To quantify neuronal excitability, the rising slope 
of action potentials (excitability slope) was quantified.  Specifically, excitability slope 
was measured as the number of action potentials by input (from 0 pA to the level of 
somatic stimulation that induced the maximum number of action potentials).  
Furthermore, the maximum number of action potentials evoked by a single depolarizing 
step was measured for each neuron.  These alternative intrinsic excitability indices 
correct for differences in input resistance, as high input resistance can result in a large 
decrease in action potentials when high intensities of somatic stimulation is applied.  
Finally, the excitability protocols were also conducted in neurons held at resting 
membrane potential to determine if differences in resting membrane potential may induce 
modifications in intrinsic neuronal excitability. 
Monosynaptic glutamatergic currents were recorded from PL-mPFC pyramidal 
neurons in voltage-clamp mode.  First, spontaneous EPSCs (sEPSCs) were recorded to 
allow identification of both presynaptic (sEPSC frequency) and postsynaptic (sEPSC 
amplitude) modifications in PL-mPFC.  To record sEPSCs, neurons were held at -80 mV 
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in the presence of the GABAA receptor antagonist picrotoxin for a minimum of 60 
seconds.  Next, EPSCs were evoked using presynaptic stimulation applied with a bipolar 
concentric microelectrode placed within 250 µm of the recording electrode.  Considering 
that AMPAr EPSCs but not NMDAr EPSCs are detectable at -80 mV, we first measured 
the maximum monosynaptic AMPAr EPSCs for each neuron at -80 mV via stepwise 
presynaptic input.  After identifying the maximum presynaptic input for monosynaptic 
AMPAr EPSCs, we induced and averaged a minimum of 8 AMPA EPSCs (0.067 Hz) 
using that intensity of presynaptic stimulation.  Next, neurons were depolarized to -35 
mV.  Both AMPA and NMDA receptors contribute to the total excitatory current at -35 
mV (Figure 21), and the relative amount of AMPAr current between -80 mV and -35 mV 
is linear even if AMPArs are inward-rectifying (Clem and Huganir, 2010).  Thus, a 
minimum of 8 EPSCs were evoked (0.067 Hz) at -35 mV to assess the relative amount of 
NMDAr current as compared with AMPAr current (AMPA:NMDA ratio).  The 
AMPA:NMDA ratio was then calculated by dividing the peak of averaged EPSCs at -80 
mV by the peak at -35 mV.  To confirm that this was an accurate calculation of the 
AMPA:NMDA ratio, we recalculated the AMPA:NMDA ratio in a subset of neurons by 
applying the NMDAr antagonist APV (50 µM) while recording evoked EPSCs at -35 mV 
(0.067 Hz).  The following equation was then used as the second index of the 
AMPA:NMDA ratio: 
 
 
 
 
EPSC after APV (AMPA) 
EPSC before APV (AMPA+NMDA) – EPSC after APV (AMPA) 
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Presynaptic plasticity was also characterized via the paired-pulse ratio (PPR).  
Neurons were held at -80 mV in the presence of picrotoxin, and 2 presynaptic pulses 
were applied with an inter-stimulation interval of 250 ms (4.0 Hz).  The peak of the 
second EPSC was then divided by the peak of the first EPSC (P2/P1) for quantification of 
the PPR. 
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Figure 20 
 
 
Figure 20.  Summary of experimental design as described in aim 2.  Arrows represent 
microinfusions 15 minutes before or immediately after behavioral testing.  CPP, 
conditioned place preference; sEPSC, spontaneous excitatory postsynaptic current. 
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Figure 21 
 
 
 
Figure 21.  Focal stimulation induces monosynaptic, glutamate receptor-specific 
postsynaptic currents in mPFC neurons.   (A) Photomicrographs of biocytin-filled mPFC 
pyramidal and GABAergic neurons.  Scale bar represents 100 µm.  (B)  Example traces 
of evoked EPSCs (50, 150, and 350 µA) in the presence of the GABAA antagonist 
picrotoxin (100 µM) and AMPAr antagonist DNQX (10µM).  (C) Evoked EPSCs were 
larger in mPFC pyramidal neurons (n = 15) as compared with GABAergic interneurons 
(n = 5).  (D-F)  Evoked EPSCs were glutamatergic, as application of the selective 
GluN2B-containing NMDAr antagonist ifenprodil (3 µM) and nonselective NMDAr 
antagonist APV (25 µM) abolished the EPSCs (Otis et al., 2014b).  **p < 0.01 compared 
with baseline. ^ p < 0.01 compared with ifenprodil-treated neurons. 
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Results 
Aim 1 
The effects of PL-mFPC β-AR blockade on retrieval and subsequent 
reinstatement of 1) contextual fear memories, 2) delay fear memories, and 3) trace fear 
memories was first investigated. 
 
Context fear conditioning 
 The necessity of PL-mPFC β-AR activation for recent contextual fear memory 
retrieval was first examined.  One day following contextual fear conditioning, rats were 
given daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 6) or 
nadolol (n = 4) before the first test only.  Nadolol reduced freezing during the first test (t8 
= 2.65, p = 0.03; Figure 22a-c), but not during subsequent nadolol-free tests (all t-values 
< 1, all p-values > 0.05).  Thus, PL-mPFC β-AR activation is required for fear expression 
during a recent context fear memory retrieval test, but disruption of this activity does not 
induce persistent fear memory impairments.   
Next, the requirement of PL-mPFC β-AR activation for remote contextual fear 
memory retrieval was assessed.  Thirty-one days following contextual fear conditioning, 
rats were given daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 
6) or nadolol (n = 7) before the first test only.  Nadolol reduced freezing during the first 
test (t11 = 2.35, p = 0.04; Figure 22d-f), but not during subsequent nadolol-free tests (all t-
values < 1, all p-values > 0.05).  Thus, PL-mPFC β-AR activation is required for fear 
expression during recent and remote context fear memory retrieval tests, but disruption of 
this activity does not induce persistent fear memory impairments.  
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Figure 22. PL-mPFC β-AR blockade prevents retrieval of recent and remote 
contextual fear memories.  (a)  PL-mPFC microinfusions of nadolol before a recent 
context retrieval test (day 1) reduced freezing, but did not have any persistent effects on 
freezing during subsequent drug-free tests.  (b) PL-mPFC microinfusions of nadolol 
before a remote context retrieval test (day 31) reduced freezing, but did not have 
persistent effects on freezing during subsequent drug-free tests. *p < 0.05. 
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Delay fear conditioning 
 The involvement of PL-mPFC β-AR activation for recent delay fear memory 
retrieval was investigated.  One day following delay fear conditioning, rats were given 
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 7) or nadolol (n 
= 8) before the first test only.  Nadolol prevented recent fear memory expression, but did 
not have long-lasting effects on fear expression.  During the first test, nadolol did not 
significantly reduce freezing during the baseline period (t13 = 1.60, p = 0.13) or post CS 
period (t13 = 2.08, p < 0.06; Figure 23a-c).  However, nadolol reduced freezing during 
presentation of the CS (t13 = 3.23, p = 0.007), indicating that recent delay fear memory 
expression was reduced.  In contrast, nadolol had no effect on freezing during subsequent 
nadolol-free tests (all t-values < 1.3, all p-values > 0.05).  Thus, PL-mPFC β-AR 
activation is required for fear expression during a recent delay fear memory retrieval test, 
but disruption of this activity does not induce persistent fear memory impairments.   
 Next, the requirement of PL-mPFC β-AR activation for remote delay fear 
memory retrieval was assessed.  Thirty-one days following delay fear conditioning, rats 
were given daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 10) 
or nadolol (n = 8) before the first test only.  Nadolol had no effect on freezing during the 
first test or during subsequent nadolol-free tests (all t-values < 2.0, all p-values > 0.05; 
Figure 23d-f).  Thus, β-AR activation is necessary for fear expression during a recent, but 
not remote, delay fear memory retrieval test 
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Figure 23 
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Figure 23.  PL-mPFC β-AR blockade prevents retrieval of recent but not remote 
delay fear memories.  (a-c)  PL-mPFC microinfusions of nadolol before a recent delay 
fear memory retrieval test (day 1) reduced freezing during CS presentation, but did not 
have persistent effects on freezing during subsequent drug-free tests.  (d-f) PL-mPFC 
microinfusions of nadolol before a remote delay fear memory retrieval test (day 31) did 
not reduce freezing during that test or during subsequent drug-free tests.  **p < 0.01.    
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Trace fear conditioning 
 The involvement of PL-mPFC β-AR activation for recent trace fear memory 
retrieval was investigated.  One day following trace fear conditioning, rats were given 
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 5) or nadolol (n 
= 5) before the first test only.  Nadolol had no effect on freezing during the first test or 
during subsequent nadolol-free tests (all t-values < 2.0, all p-values > 0.05; Figure 24a-c).  
Thus, β-AR activation is not required for fear expression during a recent trace fear 
memory retrieval test. 
Next, the requirement of PL-mPFC β-AR activation for remote trace fear memory 
retrieval was assessed.  Thirty-one days following trace fear conditioning, rats were given 
daily memory retrieval tests with PL-mPFC microinfusions of saline (n = 5) or nadolol (n 
= 4) before the first test only.  Nadolol prevented trace fear memory expression during 
this test and during a subsequent UCS-induced reinstatement test (Figure 24d-f).  During 
the first test, nadolol had no effect on freezing during the baseline period (t8 = 0.92, p = 
0.39).  However, nadolol reduced freezing during presentation of the CS (t8 = 3.52, p = 
0.01) and during the post-CS period (t8 = 11.32, p = 0.000009), indicating nadolol 
reduced remote trace fear memory expression.  In contrast, nadolol had no effect on 
freezing during the next nadolol-free test or during the final nadolol-free extinction test 
(all t-values < 1.3, all p-values > 0.05).  During the nadolol-free reinstatement test, 
however, previous nadolol treatment significantly reduced freezing during the baseline 
period (t8 = 3.52, p = 0.01) and during the post CS period (t8 = 3.18, p = 0.02).  However, 
freezing during presentation of the CS was not significantly reduced (t8 = 3.52, p = 0.01).  
Taken together, β-AR activation is necessary for fear expression during a remote, but not 
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recent, trace fear memory retrieval test.  Moreover, disruption of β-AR activity during 
remote trace fear memory retrieval prevents subsequent reinstatement of the memory.  
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Figure 24 
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Figure 24.  PL-mPFC β-AR blockade prevents retrieval and subsequent 
reinstatement of remote trace fear memory.  (a-c)  PL-mPFC microinfusions of 
nadolol before a recent trace fear retrieval test (day 1) did not reduce freezing during that 
test or during subsequent drug-free tests (d-f) PL-mPFC microinfusions of nadolol before 
a remote trace fear memory retrieval test (day 31) reduced freezing during that test and 
during a subsequent UCS-induced reinstatement.  *p < 0.05, **p < 0.01, *****p < 
0.00001. 
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Aim 2 
 The mechanisms of cocaine-associated memory retrieval impairments were next 
investigated.  Following conditioning, rats were given two daily CPP tests, with systemic 
injections of saline (n = 15) or propranolol (n = 6; 10 mg/kg) before the first test only.  
Similar to previous investigations, propranolol prevented CPP expression during the CPP 
test and during a subsequent propranolol-free CPP test (Figure 21a).  Repeated measures 
ANOVA revealed an effect of group (F1,19 = 11.74, p = 0.003), and post-hoc comparisons 
revealed that CPP-S rats had significantly higher CPP scores as compared with CPP-P 
rats during the first and second CPP tests (ps < 0.01).  Thus, propranolol persistently 
impaired retrieval of the cocaine-induced CPP memory, consistent with previous findings 
(Otis and Mueller, 2011; Otis et al., 2013).   
  
Intrinsic excitability (-70 mV) 
 β-AR blockade before the first CPP test induced a CPP memory retrieval 
impairment, but whether CPP conditioning or β-AR blockade modifies the intrinsic 
excitability of PL-mPFC neurons is unknown.  Thus, one hour following the second CPP 
test, rats were sacrificed and electrophysiological recordings were obtained from PL-
mPFC neurons held at a voltage of -70 mV.  We found subtle potentiation in the 
excitability of PL-mPFC neurons after CPP conditioning, and this enhancement was not 
modified by propranolol treatment (Figure 26a-d).  First, no differences in the number of 
evoked action potentials were found overall in neurons taken from naïve (n = 14), CPP-S 
(n = 36), and CPP-P rats (n = 23).  ANOVA revealed no input by group interaction 
(F20,700 = 1.23, p = 0.22), suggesting that the number of evoked action potentials were 
similar across groups.  Despite this, further analysis revealed that the excitability slope 
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(rising slope of spikes by level of somatic depolarization) for CPP-S and CPP-P may 
have increased following CPP conditioning.  One-way ANOVA revealed a trend between 
groups (F2,70 = 2.70, p = 0.07), and post-hoc analysis revealed that neurons from CPP-S 
and CPP-P rats had a significantly higher excitability slopes as compared with neurons 
from naïve rats (ps < 0.05).  In contrast, no differences were found between CPP-S and 
CPP-P rats (p = 0.65).  Furthermore, no overall differences between groups were found 
for the maximum number of evoked spikes (one-way ANOVA: F2,70 = 2.04, p = 0.14), 
although direct comparison between neurons taken from naïve and both CPP-s and CPP-
P rats revealed an increase in the maximum number of spikes for PL-mPFC neurons 
following CPP conditioning (Figure 22d, t71 =2.04, p <0.05).  These data indicate that 
CPP conditioning may induce a subtle potentiation in the excitability of PL-mPFC 
pyramidal neurons.   
 We next examined whether the excitability of PL-mPFC pyramidal neurons 
changed in all rats, or specifically in rats showing CPP memory retrieval.  Rats were split 
into groups expressing CPP scores below the mean (< 335 seconds, N = 3) versus those 
expressing CPP scores above the mean (>335 seconds, N = 8).  Rats with CPP scores 
above the mean (high retrieval, HR) had significantly elevated CPP scores as compared 
with rats expressing CPP scores below the mean (low retrieval, LR; Figure 26e).  
Repeated measures ANOVA revealed a between groups effect (F1,9 = 6.34, p = 0.03), and 
post-hoc analyses confirmed a significant increase in CPP for HR rats as compared to LR 
rats during the second CPP test (p = 0.0005), although no significant difference during 
the first test (p = 0.24).  Thus, HR rats expressed higher CPP scores as compared to LR 
rats.  Next, we analyzed the excitability of PL-mPFC neurons from these rats while 
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holding the neurons at -70 mV.  PL-mPFC pyramidal neurons from HR rats (n = 22) had 
increased excitability as compared with those from both LR rats (n = 14) and naïve rats (n 
= 14; Figure 26f-h).  Repeated-measures ANOVA indicated an input by group interaction 
for the number of evoked spikes (F20,470 = 3.54, p = 0.000001), revealing that the 
excitability of PL-mPFC neurons was different between groups.  One-way ANOVA 
further confirmed that excitability slope was different between groups (F2,47 = 8.07, p < 
0.001) and maximum spikes was different between groups (F2,47 = 8.33, p < 0.001).  
Finally, post-hoc analysis revealed that neurons from HR rats had significantly higher 
excitability slope (ps < 0.003) and maximum spikes (ps = 0.001) as compared with 
neurons from naïve and LR rats.  These data reveal that the intrinsic neuronal excitability 
of PL-mPFC pyramidal neurons is increased in rats expressing high CPP memory 
retrieval, but not in rats expressing low CPP memory retrieval.   
We also found that CPP memory retrieval positively correlated with intrinsic 
neuronal excitability (Figure 27).  CPP scores from CPP-S rats correlated with 
excitability slope (r9 = 0.73, p = 0.01) and maximum spikes (r9 = 0.77, p = 0.006) when 
neurons were held at -70 mV.  In contrast, CPP scores from CPP-P rats did not correlate 
with excitability slope (r4 = -0.61, p = 0.20) or maximum spikes (r4 = -0.66, p = 0.16) 
when neurons were held at -70 mV.  Taken together, these data indicate that enhancement 
of PL-mPFC neuronal excitability supports CPP memory retrieval.  Furthermore, 
inhibition of PL-mPFC β-AR activation, which limits PL-mPFC excitability (Otis et al., 
2013), may prevent PL-mPFC neuronal excitability from supporting memory retrieval.    
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Figure 25.  β-AR blockade persistently impairs expression of a cocaine CPP 
memory.  Systemic injections of propranolol, but not saline, before the first CPP test 
prevented rats from expressing a cocaine CPP during the first test and during a 
subsequent propranolol-free test (similar to previous observations by Otis and Mueller, 
2011).  **p < 0.01. 
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Figure 26.  Cocaine conditioning increases the excitability of PL-mPFC pyramidal 
neurons (held at -70 mV) in rats expressing robust CPP memory retrieval.  (a) 
Example waveforms revealing the number of action potentials evoked following somatic 
depolarization of PL-mPFC pyramidal neurons.  (b) The number of evoked spikes was 
unchanged overall between naïve, CPP-S, and CPP-P rats.  (c, d)  The excitability slope 
and maximum number of spikes was increased in rats that underwent CPP conditioning.  
(e) Rats were split into groups expressing low and high retrieval.  (f-h) The number of 
evoked spikes, excitability slope, and maximum spikes was increased in neurons taken 
from HR rats versus LR and naïve rats.  LR, low retrieval; HR, high retrieval.  *p < 0.05, 
***p < 0.001. 
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Figure 27.  Excitability of PL-mPFC pyramidal neurons (held at -70 mV) positively 
correlates with CPP memory retrieval.   (a, d) Overall, CPP scores from CPP-S and 
CPP-P rats do not correlate with excitability slope or maximum spikes of PL-mPFC 
neurons.  (b, e) CPP scores from CPP-S rats positively correlate with excitability and 
maximum spikes of PL-mPFC neurons.  (c, f) CPP scores from CPP-P rats do not 
positively correlate with excitability slope or maximum spikes of PL-mPFC neurons. 
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Intrinsic excitability (resting membrane potential) 
 Differences in PL-mPFC resting membrane potential could contribute to the 
cocaine conditioning-induced modifications in PL-mPFC intrinsic neuronal excitability.  
To assess this, we replicated excitability recordings in neurons held at resting membrane 
potential.   These recordings yielded an identical pattern of results, indicating that CPP 
conditioning increases PL-mPFC neuronal excitability without modifying resting 
membrane potential (Figure 28).   
Similar to recordings at -70 mV, no differences were found for the number of 
evoked action potentials in neurons taken from naïve (n = 15), CPP-S (n = 39), and CPP-
P rats (n = 24; Figure 28a).  ANOVA revealed no input by group interaction (F20,750 = 
1.23, p = 0.22), suggesting that the number of evoked action potentials were similar 
across groups.  Despite this, further analysis revealed that the excitability slope for 
neurons taken from CPP-S and CPP-P rats may have increased following conditioning 
(Figure 28b).  One-way ANOVA revealed a trend between groups (F2,75 = 2.94, p = 0.06), 
and post-hoc analysis revealed that neurons from CPP-S and CPP-P rats had a trend 
toward higher excitability slopes as compared with neurons from naïve rats (ps < 0.07).  
Furthermore, direct comparison between naïve and cocaine-conditioned rats indicated 
that neurons taken from cocaine-conditioned rats had increased excitability slope (t76 = 
2.30, p = 0.02).  No overall differences between groups were found for the maximum 
number of spikes (one-way ANOVA: F2,75 = 2.33, p = 0.10), although direct comparison 
between neurons taken from naïve and CPP rats revealed an increase in the maximum 
number of spikes for PL-mPFC neurons following CPP conditioning (t76 = 2.06, p = 0.04; 
90 
 
 
Figure 28c).  These data provide further support that CPP conditioning increases the 
excitability of PL-mPFC neurons. 
 We next examined whether the excitability of PL-mPFC pyramidal neurons held 
at resting membrane potential was different in rats expressing high CPP memory retrieval 
versus those expressing low CPP memory retrieval.  PL-mPFC pyramidal neurons from 
HR rats (n = 24) had increased excitability as compared with those from both LR rats (n 
= 15) and naïve rats (n = 15; Figure 28d-f).  Repeated-measures ANOVA indicated an 
input by group interaction for the number of evoked spikes (F20,510 = 3.34, p = 0.000002), 
revealing that the excitability of PL-mPFC neurons was different between groups.  One-
way ANOVA further confirmed that excitability slope was different between groups 
(F2,51 = 5.43, p = 0.007) and maximum spikes was different between groups (F2,51 = 5.27, 
p = 0.008).  Finally, post-hoc analysis revealed that neurons from HR rats had 
significantly higher excitability slope and maximum spikes (ps = 0.003) as compared 
with neurons from naïve rats.  These data reveal that the intrinsic neuronal excitability of 
PL-mPFC pyramidal neurons held at resting membrane potential is increased in rats 
expressing high CPP memory retrieval, but not in rats expressing low CPP memory 
retrieval.   
We also found that CPP memory retrieval positively correlated with intrinsic 
neuronal excitability when neurons were held at resting membrane potential (Figure 29).  
CPP scores from CPP-S rats correlated with excitability slope (r9 = 0.66, p = 0.03) and 
maximum spikes (r9 = 0.74, p = 0.01) when neurons were held at resting membrane 
potential.  In contrast, CPP scores from CPP-P rats did not significantly correlate with 
excitability slope (r4 = -0.52, p = 0.29) or maximum spikes (r4 = -0.73, p = 0.10) when 
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neurons were held at resting membrane potential.  Taken together, these data indicate that 
enhancement of PL-mPFC neuronal excitability supports CPP memory retrieval, and 
changes in resting membrane potential do not ameliorate this effect.  Despite this, how β-
AR activity maintains CPP memory retrieval remains to be determined. 
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Figure 28.  Cocaine conditioning increases the excitability of PL-mPFC pyramidal 
neurons (held at resting membrane potential) in rats expressing robust CPP 
memory retrieval.  (a) The number of evoked spikes was unchanged overall between 
naïve, CPP-S, and CPP-P rats.  (b, c)  The excitability slope and maximum number of 
spikes was increased in rats that underwent CPP conditioning.  (d-f) The number of 
evoked spikes, excitability slope, and maximum spikes was increased in neurons taken 
from HR rats versus LR and naïve rats.  LR, low retrieval; HR, high retrieval.  *p < 0.05, 
***p < 0.001. 
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Figure 29 
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Figure 29.  Excitability of PL-mPFC pyramidal neurons (held at resting membrane 
potential) positively correlates with CPP memory retrieval.   (a, d) Overall, CPP 
scores from CPP-S and CPP-P rats do not correlate with excitability slope or maximum 
spikes of PL-mPFC neurons.  (b, e) CPP scores from CPP-S rats positively correlate with 
excitability and maximum spikes of Pl-mPFC neurons.  (c, f) CPP scores from CPP-P rats 
do not positively correlate with excitability slope or maximum spikes of PL-mPFC 
neurons. 
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Synaptic plasticity 
 CPP conditioning increases the excitability of PL-mPFC pyramidal neurons, and 
this excitability is associated with CPP memory retrieval.  Despite this, how β-AR 
activation maintains CPP memory retrieval remains unclear.  Thus, we recorded sEPSCs 
(-80 mV) from PL-mPFC neurons taken from naïve (n = 9), CPP-S (n = 27), and CPP-P 
rats (n = 17).  Next, sEPSC amplitude was analyzed as a measure of postsynaptic 
plasticity, whereas sEPSC frequency was analyzed as a measure of presynaptic plasticity.  
Data reveal that the sEPSC amplitude and frequency were increased in cocaine-
conditioned rats, and propranolol reversed this change (Figure 30).  One-way ANOVA 
revealed a significant effect of group for sEPSC amplitudes (F2,50 = 12.65, p = 0.00004), 
and post-hoc analyses confirmed an increase sEPSC amplitude for neurons from CPP-S 
rats as compared with naïve and CPP-P rats (ps < 0.004).  Similarly, one-way ANOVA 
revealed a significant effect of group for sEPSC frequency (F2,50 = 5.37, p = 0.008), and 
post-hoc analyses confirmed an increase in sEPSC frequency for neurons from CPP-S 
rats as compared with naïve and CPP-P rats (ps < 0.03).  Thus, CPP conditioning 
increased the amplitude and frequency of sEPSCs in PL-mPFC pyramidal neurons, 
indicating postsynaptic and presynaptic potentiation, respectively.  Moreover, β-AR 
blockade during memory retrieval reversed this plasticity.   
 The changes in sEPSC amplitude indicate postsynaptic modifications, possibly 
due to potentiation of AMPAr currents.  To investigate this, AMPA:NMDA ratios were 
recorded.  EPSCs were evoked at -80 mV (AMPAr currents) and -35 mV (NMDAr 
currents) in PL-mPFC neurons taken from naïve (n = 7), CPP-S (n = 16), and CPP-P rats 
(n = 12).  Data reveal an increase in AMPA:NMDA ratio in neurons taken from cocaine-
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conditioned rats, and propranolol reversed this plasticity (Figure 31a,b).  One-way 
ANOVA revealed a significant effect of group (F2,32 = 16.39, p = 0.00001), and post-hoc 
analyses confirmed an increase AMPA:NMDA ratio in neurons taken from CPP-S rats as 
compared with naïve and CPP-P rats (ps < 0.001).  Thus, CPP conditioning increased the 
AMPA:NMDA ratio, and this increase was reversed by propranolol.  We confirmed these 
findings by re-calculating the AMPA:NMDA ratio by applying APV, the NMDAr 
antagonist, in neurons taken from naïve (n = 3), CPP-S (n = 5), and CPP-P rats (n = 3).  
Similar to the above findings, cocaine conditioning increased the AMPA:NMDA ratio, 
and this increase was reversed by propranolol injections before the first memory retrieval 
test (Figure 32a-b).  One-way ANOVA revealed an effect of group (F2,8 = 5.08, p = 0.04), 
and post-hoc analyses confirmed an increase in AMPA:NMDA ratio for neurons taken 
from CPP-S rats as compared with naïve and CPP-P rats (ps < 0.05).  Moreover, 
AMPA:NMDA ratios measured by voltage were positively correlated with those 
measured by APV in the same PL-mPFC neurons (r9 = 0.92, p < 0.00001).  Thus, CPP 
conditioning increased the AMPA:NMDA ratio, as measured using voltage clamp or 
APV, and this effect was reversed by propranolol.  These findings indicate a long-term 
enhancement in AMPAr currents following cocaine CPP conditioning, and this synaptic 
plasticity is reversed by β-AR blockade during CPP memory retrieval. 
 Along with postsynaptic plasticity, the sEPSC frequency was increased in PL-
mPFC neurons from cocaine-conditioned rats, indicating presynaptic plasticity.  To 
further investigate this we recorded the PPR, a second marker of presynaptic plasticity, in 
neurons taken from naïve (n = 7), CPP-S (n = 18), and CPP-P (n = 17) rats.  Cocaine 
conditioning increased the PPR in PL-mPFC neurons, an effect that was reversed by 
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propranolol (Figure 31c,d).  One-way ANOVA revealed a significant effect of group 
(F2,39 = 9.62, p = 0.00004), and post-hoc analyses confirmed an increased PPR for 
neurons taken from CPP-S rats as compared with naïve and CPP-P rats (ps < 0.003).  
Thus, CPP conditioning induced paired-pulse facilitation in PL-mPFC neurons, 
indicating presynaptic potentiation.  Moreover, this presynaptic plasticity was reversed by 
propranolol. 
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Figure 30 
 
Figure 30.  β-AR blockade during memory retrieval reverses cocaine conditioning-
induced potentiation of PL-mPFC sEPSCs.  (a) Example waveforms of PL-mPFC 
sEPSCs from PL-mPFC pyramidal neurons.  Scale bars represent 50 pA (vertical) and 
100 ms (horizontal).  (b) Cumulative frequency distribution and means plot reveal an 
increase in the amplitude of sEPSCs in neurons from CPP-S rats versus CPP-P and naïve 
rats.  (c) Cumulative frequency distribution reveals a decrease in the sEPSC inter-event 
interval, and the means plot confirms that the frequency of sEPSCs increased in neurons 
taken from CPP-S versus CPP-P and naïve rats.  **p < 0.01. 
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Figure 31 
 
Figure 31.   β-AR blockade reverses cocaine conditioning-induced AMPAr 
potentiation and paired-pulse facilitation in PL-mPFC neurons.  (a) Example 
waveforms of evoked EPSCs at -80 mV (blue traces, AMPAr EPSCs) and -35 mV (red 
traces, NMDAr EPSCs) that were used to quantify AMPA:NMDA ratios.  (b) 
AMPA:NMDA ratios were increased in neurons from CPP-S rats versus CPP-P and naïve 
rats.  (c) Example waveforms revealing PPRs (P2/P1) in PL-mPFC neurons.  (d) PPRs 
were increased in neurons from CPP-S rats versus CPP-P and naïve rats. Scale bars 
represent 50 pA (vertical) and 100 ms (horizontal).  P2/P1, pulse 2 divided by pulse 1  
**p < 0.01, ***p < 0.001. 
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Figure 32 
 
Figure 32.   Confirmation that β-AR blockade reverses cocaine conditioning-induced 
AMPAr potentiation in PL-mPFC neurons.  (a) Example waveforms of evoked EPSCs 
at -35 mV after APV application (blue, AMPAr EPSCs) and the calculated difference 
(red, NMDAr EPSCs).  (b) AMPA:NMDA ratios recorded via APV application were 
increased in neurons from CPP-S rats versus CPP-P and naïve rats.  (c) AMPA:NMDA 
ratios as recorded by voltage clamp positively correlate with AMPA:NMDA ratios 
recorded by APV application in the same PL-mPFC neurons. 
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 Data reveal presynaptic and postsynaptic plasticity in PL-mPFC neurons 
following cocaine conditioning.  Moreover, this plasticity is reversed by β-AR blockade 
during memory retrieval.  Next we confirmed that this reversal was specific to β-AR 
blockade during CPP memory retrieval, and not due to nonspecific effects such as 
reconsolidation blockade.  Following conditioning, rats were given two daily CPP tests 
with systemic injections of propranolol after the first test only (N = 5, CPP-PP, Figure 
33a).  One hour after the second test, rats were sacrificed for patch clamp 
electrophysiology.  Overall, data reveal that posttest injections of propranolol did not 
reverse the increase in PL-mPFC synaptic potentiation (Figure 33b-h).  First, sEPSC 
amplitudes were increased in neurons taken from CPP-PP rats (n = 5) as compared with 
neurons taken from naïve rats (n = 9; t12 = 3.12, p = 0.009).  Similarly, sEPSCs were 
more frequent in neurons taken from CPP-PP rats (n = 5) as compared with those from 
naïve rats (n = 9; t12 = 2.95, p = 0.01).  These indicate that propranolol has no effect on 
presynaptic and postsynaptic plasticity in PL-mPFC when given after memory retrieval.  
In further support of this, neurons taken from CPP-PP rats (n = 5) had increased 
AMPA:NMDA ratio (as measured by voltage) as compared with neurons taken from 
naïve rats (n = 7; t10 = 2.19, p = 0.05).  Finally, the PPR was increased in neurons taken 
from CPP-PP rats (n = 7) as compared with neurons taken from naïve rats (n = 7; t12 = 
3.78, p = 0.003).  Taken together, β-AR blockade after CPP memory retrieval did not 
reverse the change in sEPSC amplitude, sEPSC frequency, AMPA:NMDA ratio, or PPR.  
Thus, these data confirm that β-AR activation during memory retrieval, but not after, 
maintains cocaine-related plasticity in PL-mPFC pyramidal neurons. 
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Figure 33 
 
Figure 33.  Post-retrieval propranolol does not reverse cocaine conditioning-induced 
presynaptic and postsynaptic plasticity in PL-mPFC neurons.  (a) Post-test 
propranolol injections did not prevent CPP expression during a subsequent propranolol-
free test.  (b-d) sEPSC frequency and amplitude were increased in PL-mPFC neurons 
from CPP-PP rats versus naïve rats.  (e,f) AMPA:NMDA ratios as measured by voltage 
clamp were increased in PL-mPFC neurons from CPP-PP rats versus naïve rats.  (g,h) 
PPRs were increased in PL-mPFC neurons from CPP-PP rats versus naïve rats.  *p < 
0.05, **p < 0.01. 
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Discussion 
This dissertation aims (1) to establish whether PL-mPFC β-AR activation is a 
fundamental mechanism for maintenance of memory retrieval and (2) to determine the 
mechanism of cocaine-associated memory retrieval impairments.   
Results reveal that PL-mPFC β-AR activation is not a fundamental mechanism 
required for maintenance of fear memory retrieval.  PL-mPFC infusions of the β-AR 
antagonist nadolol reduced fear during context, recent delay, and remote trace fear 
memory retrieval tests, but had no effect during a subsequent retrieval test.  However, 
PL-mPFC β-AR blockade during the remote trace fear memory retrieval test reduced 
subsequent reinstatement, indicating some long-lasting effects of β-AR blockade on the 
fear memory.  Next, results reveal the mechanism of cocaine-associated memory retrieval 
impairments.  Cocaine conditioning increased intrinsic neuronal excitability of PL-mPFC 
neurons, particularly in rats expressing high CPP memory retrieval.  Further, cocaine 
conditioning induced presynaptic and postsynaptic potentiation in PL-mPFC neurons.  
Finally, systemic injections of the β-AR antagonist propranolol during, but not after 
retrieval, reversed the synaptic plasticity in PL-mPFC neurons.  Taken together, reversal 
of PL-mPFC synaptic potentiation by β-AR blockade induces long-lasting cocaine-
associated memory retrieval impairments, but not long-lasting fear memory retrieval 
impairments. 
 
Aim 1 
 Data reveal that PL-mPFC β-AR blockade reduced fear during recent and remote 
contextual fear memory retrieval tests.  These findings are consistent with data revealing 
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PL-mPFC inactivation reduces contextual fear memory expression 24h after conditioning 
(Corcoran and Quirk, 2007; Laurent and Westbrook, 2009).  Similarly, PL-mPFC lesions 
prevent context-dependent cued fear expression 8d after conditioning (Kim et al., 2013), 
supporting the idea that PL-mPFC regulates both recent and remote contextual fear 
memories.  Unit recording data further reveal that PL-mPFC neurons exhibit context-
dependent short-latency responses to a fear-conditioned cue (Kim et al., 2013).  Taken 
together, PL-mPFC neurons may encode contextual information for fear expression.  Our 
data further reveal that PL-mPFC β-AR activation promotes neural activity in PL-mPFC 
neurons for expression of recent and remote contextual fear memories. 
 PL-mPFC β-AR blockade reduced fear expression during a recent delay fear 
memory retrieval test, but not during a remote delay fear memory retrieval test.  
Inactivation of PL-mPFC also reduces recent delay fear memory expression (Corcoran 
and Quirk, 2007; Sierra-Mercado et al., 2011).  In contrast, microstimulation of PL-
mPFC increases fear expression when a delay fear conditioned cue is presented, whereas 
PL-mPFC microstimulation alone does not induce fear (Vidal-Gonzalez et al., 2006).  
Finally, PL-mPFC, neurons exhibit sustained tone responses during presentation of a 
recently fear-conditioned cue, and this firing correlates with delay fear expression 
(Burgos-Robles et al., 2009).  Thus, these data are consistent with the idea that β-AR 
signaling in PL-mPFC neurons support the neural activity required for recent delay fear 
memory retrieval.   
PL-mPFC β-AR blockade reduced fear expression during a remote trace fear 
memory retrieval test, but not during a recent trace fear memory retrieval test.  Although 
much evidence supports the involvement of PL-mPFC for trace fear conditioning (Baeg 
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et al., 2001; Gilmartin and McEchron, 2005; Gilmartin and Helmstetter, 2010; Guimarais 
et al., 2011; Gilmartin et al., 2013), only one recent study has examined the necessity of 
PL-mPFC for expression of a recent and remote trace fear memories.  Beeman and 
colleagues (2013) found that lesions made 30d following conditioning reduces freezing 
during a remote trace fear memory retrieval test.  In contrast, lesions made 1d following 
conditioning had no effect on freezing during a recent trace fear memory retrieval test 
(Beeman et al., 2013).  Overall, these data support the conclusion that PL-mPFC β-AR 
signaling is required for remote trace fear memory retrieval, but not recent trace fear 
memory retrieval.  The mechanism by which this PL-mPFC β-AR activation allows 
subsequent reinstatement of the trace fear memory, however, is unclear. 
Results reveal that fear memory retrieval is not susceptible to memory retrieval 
impairments by PL-mPFC β-AR blockade.  However, unpublished data from several labs 
indicate that fear memories are susceptible to memory retrieval impairments.  For 
example, oral administration of a β-AR antagonist persistently reduces cue-induced fear 
expression and subsequent reinstatement in humans (Kroes et al, 2012 SfN Abstracts).  
Furthermore, pharmacological or optogenetic inactivation of paraventricular thalamic 
neurons reduces delay fear memory retrieval in rodents during a retrieval test and during 
a subsequent manipulation-free test (Do-Monte et al, 2013 SfN Abstracts).  Taken 
together, fear memories can be persistently impaired during retrieval.  Despite this, future 
experiments need to be performed to determine the particular mechanisms that maintain 
fear memory retrieval. 
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Aim 2 
 Experiments described in aim 2 reveal the mechanism of memory retrieval 
impairments.  Cocaine conditioning increased the intrinsic excitability of PL-mPFC 
pyramidal neurons, particularly in rats expressing high CPP memory retrieval.  
Furthermore, cocaine conditioning increased sEPSC frequency and induced paired-pulse 
facilitation in PL-mPFC pyramidal neurons, indicative of presynaptic potentiation.  
Cocaine conditioning also increased sEPSC amplitude and AMPA:NMDA ratios, 
indicative of postsynaptic potentiation.  Finally, β-AR blockade during but not after a 
CPP test induced persistent impairments in CPP memory retrieval and reversed 
modifications in sEPSC frequency, sEPSC amplitude, PPR, and AMPA:NMDA ratios.  
In contrast, β-AR blockade during memory retrieval did not reverse modifications in 
intrinsic neuronal excitability.  Taken together, CPP memory retrieval impairments are 
likely due to reversal of cocaine-related synaptic potentiation in PL-mPFC pyramidal 
neurons. 
 
Intrinsic plasticity 
 Cocaine conditioning increased the excitability of PL-mPFC pyramidal neurons in 
rats expressing high CPP memory retrieval but not low CPP memory retrieval.  
Furthermore, PL-mPFC neuronal excitability positively correlated with CPP expression, 
unless the β-AR antagonist propranolol was administered during memory retrieval.  
These data are consistent with previous observations that cocaine increases the 
excitability of neurons in mPFC.  Repeated systemic administration of cocaine decreases 
conductance of voltage-gated K
+
 channels (mainly slowly inactivating (ID) K
+
 channels), 
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resulting in enhanced membrane excitability (Dong et al., 2005; Nasif et al., 2005b).  
Furthermore, repeated cocaine increases voltage-gated Ca
2+
 currents (IC) via enhanced 
conductance of high-voltage activated (HVA) L-type Ca
2+
 channels (Nasif et al., 2005a; 
Ford et al., 2009).  Unlike other HVA Ca
2+
 channels that control medium and slow-
afterhyperpolarization, HVA L-type Ca
2+
 channels promote repetitive firing by reducing 
the interspike interval of neocortical pyramidal neurons (Pineda et al., 1998).  Thus, 
enhanced L-type Ca
2+
 currents may contribute to the enhancement of PL-mPFC 
pyramidal neuron excitability following repeated cocaine exposure, particularly at high 
voltages which induces repetitive firing of these neurons.  To assess this, future analysis 
should be completed to assess the interspike interval of PL-mPFC neurons in cocaine-
conditioned rats versus naïve rats.  If HVA L-type Ca
2+ 
channels contribute to cocaine-
induced enhancement of PL-mPFC neuronal excitability, the interspike interval of these 
neurons should be reduced in neurons from high retrieval rats but not low retrieval rats. 
 
Synaptic plasticity 
 Cocaine conditioning induced presynaptic and postsynaptic potentiation in PL-
mPFC pyramidal neurons.  These data are consistent with investigations characterizing 
dendritic morphology of these neurons following exposure to psychostimulants.  
Systemic injections of amphetamine and cocaine, for example, increase dendritic length, 
dendritic branching, and dendritic spine density in dorsal mPFC pyramidal neurons for at 
least one month (Robinson and Kolb, 1997, 1999).  Similarly, cocaine self-administration 
increased dendritic branching and dendritic spine density in dorsal mPFC pyramidal 
neurons (Robinson et al., 2001).  These findings paralleled dendritic spine plasticity in 
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NAc medium spiny neurons (Robinson and Kolb, 1997, 1999; Robinson et al., 2001), 
which receive input from PL-mPFC neurons for expression of drug seeking (McFarland 
et al., 2003; Peters et al., 2009).  Thus, long-lasting neuroadaptations within this 
corticolimbic circuit may mediate drug-associated memory retrieval for the persistence of 
drug seeking 
Recent experiments using 2-photon microscopy in vivo confirm an increase in PL-
mPFC dendritic spine gain, and reveal no change in dendritic spine loss, in layer V dorsal 
mPFC pyramidal neurons 2h and 96h following cocaine exposure (Munoz-Cuevas et al., 
2013).  Moreover, these experiments reveal that PL-mPFC dendritic spine gain positively 
correlates cocaine CPP expression.  Thus, dendritic spine plasticity within layer V PL-
mPFC pyramidal neurons is a likely mechanism for cocaine-associated memory retrieval.  
Data described here support this idea, revealing that cocaine conditioning induces both 
presynaptic and postsynaptic plasticity within layer V PL-mPFC pyramidal neurons.  
Moreover, we found that β-AR blockade during CPP memory retrieval reversed this 
plasticity and prevented drug-associated memory retrieval.  Thus, dendritic/synaptic 
potentiation in PL-mPFC may be essential for cue-induced drug seeking.  The 
mechanism by which β-AR blockade reverses this plasticity, however, is less clear. 
 
Mechanism 
β-AR blockade induced a persistent impairment in retrieval of a cocaine-induced 
CPP memory.  This retrieval impairment could be in part due to transient limitation of 
PL-mPFC intrinsic neuronal excitability.  Presentation of salient stimuli causes activation 
of locus coeruleus noradrenergic neurons (Sterpenich et al., 2006) and provokes 
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norepinephrine release (Cassens et al., 1980).  Norepinephrine enhances the excitability 
of PL-mPFC pyramidal neurons, and this excitation is blocked by β-AR inhibition (Otis 
et al., 2013).  Thus, β-AR blockade prevents norepinephrine-induced enhancement of PL-
mPFC neuronal excitability during memory retrieval (Rodriguez-Romaguera et al., 
2009), indicating that β-AR-dependent potentiation of intrinsic excitability may maintain 
retrieval.  In support of this, unpublished data from our lab reveal that PL-mPFC protein 
kinase A (PKA)-induced inhibition of Ca
2+
-activated K
+
 channels maintains retrieval 
(Fitzgerald et al, unpublished).  This cascade is downstream of β-ARs, and is the 
mechanism by which β-AR activation increases neuronal excitability (Foehring et al., 
1989; Mueller et al., 2008).  Taken together, both CPP conditioning and cue-induced β-
AR activation increase PL-mPFC pyramidal neuron excitability, and this neuronal 
excitation is required for CPP memory retrieval. Despite this, data here reveal that 
excitability of PL-mPFC neurons remain increased after β-AR blockade during retrieval.  
Thus, long-lasting cocaine CPP memory retrieval impairments are not due to long-lasting 
reversal of PL-mPFC intrinsic neuronal excitability. 
Cocaine CPP conditioning induced intrinsic neuronal plasticity in PL-mPFC 
neurons, and this plasticity may function in unison with synaptic plasticity for the control 
of cocaine CPP memory retrieval.  Previous research reveals dendritic spine growth in 
layer V PL-mPFC pyramidal following cocaine CPP conditioning, and this spine growth 
correlates with CPP memory retrieval (Munoz-Cuevas et al., 2013).  Taken together with 
data shown here, PL-mPFC synaptic potentiation likely controls cocaine-associated 
memory retrieval.  In further support of this, memory retrieval impairments induced by β-
AR blockade were associated with reversal of synaptic potentiation in PL-mPFC. These 
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data indicate that β-AR activation during memory retrieval is critical for maintenance of 
retrieval-related synaptic plasticity.  Despite this, the mechanism underlying reversal of 
synaptic plasticity by β-AR blockade during retrieval is unclear.   
 The data described here are consistent with the hypothesis that β-AR activation 
maintains cocaine-associated memory retrieval by synchronizing PL-mPFC synaptic 
input with postsynaptic activation of PL-mPFC pyramidal neurons.  Specifically, intrinsic 
excitability of PL-mPFC neurons is increased during cocaine CPP memory retrieval, 
indicating that PL-mPFC neurons are more responsive to excitatory inputs.  In contrast, 
presynaptic input in the absence of synchronous postsynaptic action potentials can induce 
synaptic depression (Froemke and Dan, 2002; Froemke et al., 2005).  Thus, PL-mPFC β-
AR activation may maintain synchronous presynaptic and postsynaptic activity during 
retrieval, whereas disruption of this synchrony likely weakens PL-mPFC synapses.  
Consistent with this hypothesis, NE prevents spike-timing dependent depression (STDD) 
at cortical synapses (Salgado et al., 2012).  Thus, β-AR blockade during retrieval may 
induce PL-mPFC synaptic depression by causing neural asynchrony, resulting in long-
term retrieval impairments.  
 
Future Directions 
Reversal of PL-mPFC synaptic potentiation underlies cocaine-associated memory 
retrieval deficits, although the neural circuits underlying memory retrieval are not well-
defined.  To assess the neural circuits of memory retrieval, genetic approaches can be 
used to tag and manipulate the retrieval circuit both in vivo and in vitro.  For example, I 
plan to use arc-tTA transgenic mice (similar to Liu et al., 2014) along with 
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adenoantivirus transfections (AAV-Chr2-mCherry or AAV-eArchT-mCherry) to allow 
region-specific, activity-dependent tagging of neurons.  Considering that 
channelrhodopsin or archaerhodopsin are inserted within the adenoantivirus, this 
technology would allow 1) tagging of neurons that become active during memory 
retrieval, 2) optogenetic manipulation of these neurons in vivo, and 3) 
electrophysiological characterization of these neurons in vitro.  Thus, using a 
combination of behavioral, genetic, and electrophysiological approaches the neural 
circuits required for fear and drug-associated memory retrieval can be well defined.   
Evidence described here indicates that PL-mPFC layer V pyramidal neurons 
regulate memory retrieval.  However, activity of these neurons is not only influenced by 
synaptic inputs to PL-mPFC, but also by PL-mPFC interneurons.  For example, 
convincing evidence from Cyril Herry’s lab now indicate that PL-mPFC parvalbumin-
positive interneurons coordinate theta oscillations for the control of fear expression 
(Courtin et al., 2014).  Thus, monitoring the coordinated activity of many genetically-
defined neurons would allow us to define how different types of neurons coordinate 
activity within particular brain regions for memory retrieval.  Such experiments could be 
conducted using 2-photon ultrasensitive fluorescent calcium imaging (GCaMP6.0; Chen 
et al., 2013).  Using this technique along with genetic labeling of particular neurons (e.g., 
parvalbumin versus somatostatin interneurons), the neuronal assemblies which coordinate 
activity within a given brain region for memory retrieval could be determined. 
 Although PL-mPFC β-AR blockade does not persistently impair fear memory 
retrieval, evidence indicates that fear memory retrieval is susceptible to persistent 
disruption (Kroes et al, 2012 SfN Abstracts; Do-Monte et al, 2013 SfN Abstracts).  Thus, 
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future experiments should identify how fear memory retrieval is maintained.  For 
example, Do-Monte and colleagues (2013, SfN Abstracts) found that optogenetic 
inhibition of pavaraventricular thalamic inputs to the central amygdala (PVT-CeA) 
persistently reduces remote delay fear memory retrieval.  However, the mechanism by 
which the PVT-CeA pathway maintains retrieval is completely unknown.  To solve this, 
experiments using optogenetic and electrophysiological approaches should be conducted.  
For example, fear memory retrieval impairments could be induced via optogenetic 
inhibition of the PVT-CeA pathway in vivo.  Next, intrinsic and synaptic recordings of 
CeA neurons can be obtained in vitro, with EPSCs evoked via optogenetic stimulation of 
the PVT-CeA pathway.  Based on the findings presented here, synaptic depotentiation of 
PVT-CeA synapses may account for fear memory retrieval impairments.  Findings such 
as these would confirm that reversal of memory-related synaptic plasticity can occur 
during both fear memory retrieval and cocaine-associated memory retrieval. 
 
Clinical Relevance 
Presentation of drug-associated cues leads to cravings and relapse among addicts, 
whereas presentation of trauma-related cues can provoke anxiety and fear in PTSD 
patients.  Disruption of fear or drug-associated memory retrieval would therefore 
alleviate these disorders.  Data described here reveal for the first time that memory-
related synaptic plasticity is maintained by neuronal activity during retrieval.  Although 
future experiments should further elucidate the mechanisms and neural circuits that 
maintain synaptic plasticity during retrieval, these data provide the framework for 
development of therapies that could lead to elimination of cue-induced drug seeking and 
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fear.  Currently, exposure therapy involves the repeated, unreinforced presentation of 
drug or fear-related cues, inducing retrieval and extinction learning.  Although extinction 
leads to inhibition of cue-induced behaviors, spontaneous recovery and reinstatement of 
those behaviors is common.  Data described here reveal that a more direct approach of 
reversing memory-related synaptic plasticity during retrieval (i.e., during exposure 
therapy) may be possible.  Such effects would not only eliminate cue-induced behaviors, 
but would also provide long-lasting protection against spontaneous recovery and 
reinstatement.  Taken together, our findings support the use of pharmacological adjuncts 
to exposure therapy, such as β-AR antagonists, for persistent impairment of fear and 
drug-associated memory retrieval.   
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